galactosamine has been researched along with Liver Diseases in 250 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 105 (42.00) | 18.7374 |
1990's | 63 (25.20) | 18.2507 |
2000's | 61 (24.40) | 29.6817 |
2010's | 17 (6.80) | 24.3611 |
2020's | 4 (1.60) | 2.80 |
Authors | Studies |
---|---|
Baek, SI; Han, SB; Hong, JT; Hwang, BY; Jung, J; Kim, SH; Kim, Y; Lee, ES; Na, Y; Roh, YS | 1 |
Li, J; Lin, G; Lu, Y | 1 |
Du, R; Liang, Y; Liu, Y; Sheng, S; Tong, H; Wang, X; Xiu, L; Xu, R; Zhang, H | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Hu, K; Huang, J; Jiang, R; Li, L; Lin, L; Lv, X; Shen, Y; Tang, L; Wan, J; Yang, Y; Zhang, L; Zhou, H | 1 |
Kaibori, M; Kon, M; Miki, H; Nakatake, R; Nishizawa, M; Oishi, M; Okumura, T; Tanaka, Y; Tokuhara, K; Ueyama, Y | 1 |
Chen, Y; Fang, D; Gu, S; Guo, F; Guo, J; Hu, X; Li, A; Li, L; Li, Y; Lv, L; Shi, D; Wu, W; Ye, J | 1 |
Cao, L; Duan, M; Tang, J; Tian, D; Wang, F; Yao, X; Zhang, Y | 1 |
Antoine, DJ; Bajt, ML; Jaeschke, H; Jenkins, RE; Park, BK; Woolbright, BL | 1 |
El-Shazly, AM; Hamdan, DI; Mahmoud, MF; Wink, M | 1 |
Chen, W; Han, C; Song, K; Wang, Y; Wu, T; Zhang, J | 1 |
Khan, J; Saraf, S | 1 |
Chen, J; Dong, S; Li, Y; Liu, H; Wang, Y; Xie, J; Zhang, H; Zhang, Y; Zhao, S | 1 |
Chen, X; Li, W; Maggi, F; Papa, F; Shi, J | 1 |
Ba, H; Gong, F; Jiang, R; Jiang, Y; Li, C; Li, Z; Wang, J; Yang, P; Yin, B; Zhang, M; Zhou, W | 1 |
Chen, G; Hu, XY; Liu, JL; Liu, XY; Luo, JX; Nie, HM; Wen, DC; Zhang, Y | 1 |
Hou, SZ; Lai, XP; Li, G; Nagao, Y; Ye, MR; Zhu, CC | 1 |
Chen, X; Ding, WX; Ni, HM; Schuchmann, M; Yin, XM | 1 |
Chen, J; Dong, L; Guo, Z; Hong, H; Ouyang, C; Ouyang, J; Shen, C; Zeng, K; Zhang, C; Zhang, J; Zhao, Y; Zhu, J | 1 |
Chen, J; Gao, J; Michael, L; Tang, XH; Tang, YH; Xu, LZ; Zhao, XN | 1 |
Beg, AA; Chen, X; Fan, J; Liao, Y; Ni, HM; Shi, YH; Yin, XM | 1 |
Farhood, A; Hong, JY; Jaeschke, H; Lebofsky, M | 1 |
Arunsundar, M; Balaji, R; Krishnakumar, E; Ravichandiran, V; Shanmugarajan, TS; Sivaraman, D; Somasundaram, I | 1 |
Akashi, I; Hirano, T; Kagami, K; Oka, K | 1 |
Balsari, A; Cardani, D; Dusio, GF; Gariboldi, S; Marcucci, F; Mauro, V; Palazzo, M; Rumio, C; Zanobbio, L | 1 |
Agüero, G; Alvarez, S; Haro, C; Lazarte, S; Zelaya, H | 1 |
Chen, Y; Chen, YB; Li, LJ; Li, YT; Wang, HY; Wang, L; Wu, ZW | 1 |
Liu, C; Liu, P; Tao, Y; Wang, Q; Yan, X; Zhou, T | 1 |
Fei, M; Guo, H; Guo, Y; Jia, Y; Sun, S; Wang, Y; Zhang, Y; Zheng, R | 1 |
Das, J; Ghosh, J; Roy, A; Sil, PC | 1 |
Ashida, H; Ichiyanagi, T; Mukai, R; Nishiumi, S | 1 |
Arribillaga, L; Borrás-Cuesta, F; Boya, P; Casares, N; de Cerio, AL; Gorraiz, M; Lasarte, JJ; Prieto, J; Sarobe, P | 1 |
Arimoto, Y; Inakuma, T; Jinno, K; Kawagishi, H; Morita, T; Suganuma, H; Sugiyama, K | 1 |
Besra, SE; Chakravorty, AK; Das, B; Das, M; Ganguly, DK; Gomes, A; Sur, P; Vedasiromoni, JR | 1 |
Fan, S; Gao, B; Hong, F; Jaruga, B; Kim, WH; Radaeva, S | 1 |
Aeed, H; Avinoach, I; Avni, Y; Bruck, R; Hershkoviz, R; Shahmurov, M; Shirin, H; Wardi, J | 1 |
Bang, R; Kiemer, AK; Prockl, J; Schümann, J; Tiegs, G; Vollmar, AM | 1 |
HIRAYAMA, C; TADA, H; YOSHIKAWA, T | 1 |
Kobayashi, N; Kodama, M; Kunieda, T; Kurabayashi, Y; Maruyama, M; Nakaji, S; Okitsu, T; Oshita, M; Shibata, N; Takesue, M; Tanaka, N; Totsugawa, T | 1 |
Hashizume, E; Kamiya, T; Kayahashi, S; Nakagiri, R; Sakai, Y | 1 |
Morita, T; Sugiyama, K; Takahashi, K; Tanabe, H | 1 |
Doshi, M; Hamazaki, T; Ishikura, Y; Kawashima, H; Kiso, Y; Niimoto, T; Watanabe, S | 1 |
Chen, HC; Jiang, YP; Liu, YG | 1 |
He, R; Hui, LQ; Song, HY; Wan, YL; Wu, ZL; Xiong, YL; Yan, MZ; Ye, WH; Zhou, ZM; Zuo, F | 1 |
Aso, K; Ito, T; Makino, I; Nakamura, K; Okada, M; Okamoto, S; Tamaki, Y; Yokohama, S; Yoneda, M | 1 |
Baker, AJ; Hunter, RJ; Patel, VB; Preedy, VR | 1 |
Adachi, K; Arakawa, T; Fujii, H; Fujiwara, H; Ikarashi, Y; Ikemoto, M; Kaneda, K; Kawakita, N; Kitada, T; Kobayashi, S; Kronenberg, M; Mitchell, K; Nakajima, Y; Nakanishi, K; Seki, S; Taniguchi, M; Tsutsui, H | 1 |
Bostick, MK; Campe, CB; Hanson, JC; Kodali, P; Lee, G; Maher, JJ; Yan, J | 1 |
Mas, R; Mendoza, N; Mendoza, S; Noa, M | 1 |
Choi, J; Jung, HJ; Kim, WB; Lee, JH; Lee, KT; Park, HJ; Park, JK; Park, KK | 1 |
Adaramoye, OA; Adeyemi, EO | 1 |
McMillan, DC; McMillan, JM | 1 |
Chiji, H; Fukushima, M; Han, KH; Hashimoto, M; Hashimoto, N; Noda, T; Sekikawa, M; Shimada, K; Topping, DL; Yamauchi, H | 1 |
Aoki, T; Ishihara, K; Katsutani, N | 1 |
Fukushima, M; Han, KH; Hashimoto, M; Hashimoto, N; Lee, CH; Noda, T; Sekikawa, M; Shimada, K | 1 |
Kuhlmann, WD; Peschke, P | 1 |
Abe, K; Ikeda, T; Inoue, H; Matsushita, T; Sato, T; Wake, K; Yoshida, T | 1 |
Egashira, Y; Kawano, N; Sanada, H | 2 |
Arai, H; Igarashi, K; Ikeya, M; Kita, A; Takenaka, A | 1 |
Chamulitrat, W; Erben, G; Huber, A; Lehmann, WD; Stremmel, W; Thongphasuk, P; Tuma, S | 1 |
Asha, VV; Suresh, V | 1 |
Abe, K; Ikeda, T; Inoue, H; Sato, T; Wake, K | 1 |
Fukuda, Y; Ikemoto, M; Murayama, H; Nagata, A | 1 |
Matsuda, H; Morikawa, T; Ninomiya, K; Yamaguchi, I; Yasuda, D; Yoshikawa, M | 1 |
Chen, XY; Wang, F; Wen, T; Wu, H | 1 |
Bolkent, S; Catal, T | 1 |
Bäumel, M; Hehlgans, T; Lechner, A; Männel, DN | 1 |
Inoue, K; Satoh, M; Takano, H | 1 |
Fukuda, T; Hatano, T; Ito, H; Kikuchi, M; Shimoda, H; Tanaka, J; Yoshida, T | 1 |
Bode, C; Rumpelt, HJ | 2 |
Adjarov, D; Ivanov, E; Naidenova, E; Petrova, S | 1 |
Imanishi, T | 1 |
Baumgartner, D; LaPlante-O'Neill, PM; Najarian, JS; Sutherland, DE | 1 |
Ezaki, H; Kawanishi, H; Nishiki, M; Tsuchiya, T | 2 |
Buckley, AR; Karrer, FM; Putnam, CW; Rhenman, B; Steinbronn, K; Warneke, JA | 1 |
Koyama, K; Okabe, K; Ouchi, K; Sato, T | 1 |
Uchida, K | 1 |
Hara, H; Hattori, N; Ishida, Y; Noda, Y; Ohta, H; Takabatake, T | 1 |
Castillo-Olivares, JL; Cienfuegos, JA; Cuervas-Mons, V; Eroles, G; Golitsin, A; Maganto, P | 1 |
Ezaki, H; Kawanishi, H; Kimura, S; Nishiki, M; Sugiyama, M; Tsuchiya, T | 1 |
Ferenci, P; Jacobs, R; Jones, EA; Pappas, SC; Schafer, DF | 1 |
Blanc, PL; O'Neill, PL; Sutherland, DE | 1 |
Gandolfi, AJ; MacDonald, JR; Sipes, IG | 2 |
Asanuma, Y; Koyama, K; Okabe, K; Ouchi, K; Sato, T | 4 |
Chang, TM; Shu, CD | 1 |
Niu, Z | 1 |
Kagamiyama, H; Sakakibara, S; Shibayama, Y; Ueda, I | 1 |
Blasberg, RG; Fenstermacher, JD; Horowitz, ME; Jones, EA; Molnar, P; Patlak, CS; Schafer, DF; Waggoner, J | 1 |
Castro, JA; de Fenos, OM; de Ferreyra, EC | 1 |
Gibson, RG; Hirschowitz, BI; Mihas, AA; Mihas, TA | 1 |
Blendis, LM; Falk, JA; Falk, RE; Langer, B; Makowka, L; Nossal, NA; Phillips, MJ; Rotstein, LE | 1 |
Blendis, LM; Falk, JA; Falk, RE; Langer, B; Makowka, L; Nossal, N; Phillips, MJ; Rotstein, LE | 2 |
Blendis, LM; Falk, JA; Falk, RE; Langer, B; Makowka, L; Phillips, MJ; Rotstein, LE; Zuk, R | 1 |
Cornell, RP | 1 |
Hayashi, S; Higashi, T; Nagashima, H; Watanabe, A | 1 |
Farber, JL | 1 |
Gressner, AM; Grouls, P; Heinrigs, S | 1 |
Baumgartner, D; Lewis, WI; O'Neill, PL; Sutherland, DE; Zweber, BA | 1 |
Braginskiĭ, DM; Erokhina, LG; Farber, NA; Gubskiĭ, LV; Ketiladze, ES | 1 |
Kawasato, S; Nakada, H; Sameshima, Y; Sawamura, T; Shiozaki, Y; Tashiro, Y | 1 |
Wardle, EN; Williams, R | 1 |
Heine, WD; Liehr, H | 1 |
Barsig, J; Bohlinger, I; Leist, M; Tiegs, G; Uhlig, S; Wendel, A | 1 |
Chen, Y; He, X; Li, M; Li, W; Xie, T; Zhou, J | 1 |
Dixit, V; Gitnick, G | 1 |
Cantoni, L; Carelli, M; Ghezzi, P; Sironi, M; van der Meer, JW; Vogels, MT | 1 |
Hasegawa, M; Honda, Y; Hosokami, T; Ide, S; Ikeda, T; Kurebayashi, Y; Nakayama, A; Shimoto, Y; Suzuki, N; Yokohama, S | 1 |
Lin, CC; Tsai, CC; Yen, MH | 1 |
Kawamoto, T; Kawasaki, H; Nakamura, T; Okano, J; Shiota, G | 1 |
Tiegs, G | 1 |
Ariyoshi, T; Kitajima, S; Ogawa, N | 1 |
Fujiwara, K; Matsui, A; Nagoshi, S; Ohta, Y | 1 |
Bahrami, S; Leichtfried, G; Redl, H; Schlag, G; Yu, Y | 1 |
Czaja, MJ; Geerts, A; Ju, Y; Schmiedeberg, P; Xu, J | 1 |
Kimura, T; Kurosaki, Y; Nakayama, S; Nakayama, T; Yamao, T | 1 |
Dhawan, BN; Patnaik, GK; Shukla, B; Visen, PK | 1 |
Adawi, D; Bengmark, S; Gebreselassie, D; Jeppsson, B; Kasravi, FB; Molin, G; Wang, L | 1 |
Higashiyama, S; Ito, N; Kawata, S; Kiso, S; Matsuzawa, Y; Tamura, S; Taniguchi, N; Tsushima, H; Yamada, A | 1 |
Baker, AJ; Crossey, PA; Holt, RI; Jones, JS; Miell, JP; Preedy, VR; Stone, NM | 1 |
Brunori, PM; Chiorean, M; Di Matteo, FM; Fiorucci, S; Migliorati, G; Morelli, A; Santucci, L; Sidoni, A | 1 |
Kimura, T; Kurosaki, Y; Nakayama, T; Okamoto, M; Wang, Z | 1 |
Koide, N; Sasaki, S; Shinji, T; Tsuji, T | 1 |
Basnet, P; Hase, K; Kadota, S; Namba, T; Takahashi, T | 1 |
Adawi, D; Bengmark, S; Hägerstrand, I; Jeppsson, B; Kasravi, FB; Molin, G | 1 |
Cheng, CC; Egashira, Y; Etoh, J; Ohta, T; Sanada, H; Tanimura, T | 1 |
Timbrell, JA; Waterfield, CJ | 1 |
Cheng, CC; Egashira, Y; Katayama, T; Ohta, T; Sanada, H | 1 |
Fariss, MW; Lippman, HR; Mumaw, VR; Ray, SD | 1 |
Adawi, D; Jeppsson, B; Molin, G | 1 |
Doi, K; Hirasawa, K; Itagaki, S; Kawamura, S; Maeda, K; Mikami, T; Takeda, M; Tsutsui, S | 1 |
Hayashi, T; Ishiguro, I; Kongo, M; Nagata, M; Nishida, K; Ohta, Y; Sasaki, E | 1 |
He, P; Saeki, S; Sugiyama, K; Tamaki, F; Wada, S | 1 |
Sadanobu, S; Takeuchi, M; Tezuka, M | 1 |
Iwai, M; Shimazu, T; Yamauchi, T | 1 |
Cui, TX; Iwai, M; Shimazu, T; Yamauchi, T | 1 |
Ishii, H; Iwabuchi, S; Maeyama, S; Murayama, M; Nakano, M; Ro, S; Takatori, M; Uchikoshi, T | 1 |
Handa, SS; Karan, M; Vasisht, K | 1 |
Hasegawa, H; Kawaguchi, K; Kikuchi, S; Kumazawa, Y; Maruyama, H; Morita, H | 1 |
Basnet, P; Hase, K; Kadota, S; Namba, T; Xiong, Q | 1 |
Lai, TY; Lin, WC; Wu, YW | 1 |
Bando, Y; Chone, Y; Izumi, K; Jiao, Z; Kitaura, K; Nakamura, T; Ohnishi, T; Suzuki, Y; Uehara, H | 1 |
He, P; Saeki, S; Sugiyama, K; Wada, S | 1 |
Aniya, Y; Gyamfi, MA; Yonamine, M | 1 |
Bahjat, FR; Copeland, EM; Edwards, CK; Fukuzuka, K; Josephs, MD; Ksontini, R; MacKay, SL; Moldawer, LL; Solorzano, CC; Tannahill, CL | 1 |
Bahjat, FR; Edwards, CK; Gaines, GC; MacKay, SL; Minter, R; Moldawer, LL; Nowak, M; Rectenwald, J; Rosenberg, J | 1 |
Burns, AR; Collins, RG; Farhood, A; Jaeschke, H; Lawson, JA; Lynn Bajt, M; Smith, CW | 1 |
Arimoto, H; Arimoto, Y; Fukumoto, Y; Hatakeyama, M; He, P; Inakuma, T; Kawagishi, H; Matsuzawa, T; Suganuma, H; Sugiyama, K | 1 |
Adnyana, IK; Awale, S; Banskota, AH; Kadota, S; Tezuka, Y; Tran, KQ | 1 |
Chang, MJ; Choi, HS; Choi, J; Kim, HS; Kim, SH; Lim, HK | 1 |
Kohno, K; Matsuda, H; Murakami, T; Ninomiya, K; Yoshikawa, M | 1 |
Liu, B; Sun, Y; Wan, J; Xu, H | 1 |
Bahjat, FR; Edwards, CK; Moldawer, LL; Oberholzer, A; Oberholzer, C | 1 |
Hedlund, G; Klintman, D; Thorlacius, H | 1 |
Harstad, EB; Klaassen, CD | 1 |
Lagovsky, I; Meshorer, A; Novogrodsky, A; Patya, M; Vanichkin, A | 1 |
Adnyana, IK; Harimaya, Y; Kadota, S; Kurashige, Y; Saiki, I; Tezuka, Y; Tran, QK; Tran, QL | 1 |
Sato, R | 1 |
Hudig, D; Newell, L; Sell, S; Smuckler, EA | 1 |
Kobayashi, M | 1 |
Higashi, T; Nagashima, H; Watanabe, A | 1 |
Freudenberg, MA; Galanos, C; Reutter, W | 1 |
Grün, M; Liehr, H | 2 |
Matas, AJ; Najarian, JS; Simmons, RL; Sommer, BG; Sutherland, DE | 1 |
Hennings, G | 1 |
Chang, TM; Chirito, E; Lister, C | 1 |
Chang, TM; Chirito, E; Lister, C; Reiter, B | 1 |
Kuiken, LB; Ragland, JB; Sabesin, SM | 1 |
Gäng, V; Gaubitz, W; Stanjek, J | 1 |
Gerok, W; Pausch, J; Wohleb, B | 1 |
Guerrero, MA; Kositzki, H; Köstering, H; Riesenkampff, WG | 1 |
Gallenkamp, H | 1 |
El-Mofty, SK; Farber, JL; Nicolini, C; Scrutton, MC; Serroni, A | 1 |
Connelly, LJ; Koff, RS | 1 |
Abdul-Hussain, SK; Mehendale, HM | 1 |
Kawada, N; Liu, P; Mizoguchi, Y; Morisawa, S | 1 |
Chen, RD; Hu, HL; Ma, LH | 1 |
Bratt, G; Buchthal, S; Garwood, M; Hendrich, K; Merkle, H; Uğurbil, K; Weisdorf, S; Wike, J | 1 |
Agoston, S; Caldwell, JE; Gruenke, LD; Khuenl-Brady, KS; Miller, RD; Segredo, V; Sharma, ML; Shin, YS | 1 |
Kano, T; Moriwaki, H; Muto, Y; Nagaki, M; Ohnishi, H; Yamada, T | 1 |
Keegan-Rogers, V; Wu, GY | 1 |
Fausto, N; Lemire, JM; Shiojiri, N | 1 |
Alcorn, JM; Chojkier, M; Fierer, J | 1 |
Chang, TM; Kashani, SA | 2 |
Sawamura, T; Shiozaki, Y | 1 |
Etoh, H; Ishikawa, A; Misawa, S; Nakano, M; Tanaka, E | 1 |
Hickman, R; Terblanche, J | 1 |
Ishida, N; Mita, S; Nakata, K; Takase, K; Tanaka, M | 1 |
Li, ZM; Niu, Z; Wang, F | 1 |
Endo, S; Inada, K; Komuro, T; Suda, H; Takahashi, T; Tamura, S; Tanaka, S; Yoshida, M; Yoshida, T | 1 |
Chen, YN; Yang, FY; Yang, WS; Yao, ZQ; Zhang, WB | 1 |
Bay, MK; Johnson, RF; Leighton, JA; Maldonado, AL; Schenker, S; Speeg, KV | 1 |
Mito, M; Munakata, T; Tanaka, K | 1 |
Kobayashi, K; Kuroki, T; Matsui-Yuasa, I; Nakajima, S; Nishiguchi, S; Otani, S; Seki, S; Shiomi, S; Takeda, T | 1 |
Bocharov, AV; Bochkova, NA; Fedina, IB; Shnyra, AA; Spirov, VG | 1 |
Gramminger, K; Henne-Bruns, D; Kremer, B; Krüger, U | 1 |
Kobayashi, K; Kodama, C; Mizoguchi, Y; Morisawa, S; Sakagami, Y; Sakai, M; Yamada, J; Yamamoto, S | 1 |
Carter, EA; Matkin, C; Ratner, AV; Simpson, BB; Young, SW | 1 |
Kakisaka, A; Kasai, S; Mito, M | 1 |
Asano, F; Kato, M; Moriwaki, H; Muto, Y; Onishi, H; Shiratori, Y | 1 |
Samochowiec, L; Wójcicki, J | 1 |
Matsuno, N; Sano, N; Seiki, K; Sugimoto, A; Tsuji, K | 1 |
Fuwa, T; Hanano, M; Iga, T; Kim, DC; Kurita, M; Sato, H; Sugiyama, Y; Yanai, S | 1 |
Dozeman, R; Zieve, L | 1 |
Ando, T; Moriwaki, H; Muto, Y; Okuno, F; Seishima, M; Yamada, M; Yoshida, H | 1 |
Ha, TZ | 1 |
Fukuda, Y; Imoto, M; Koyama, Y; Ozawa, T; Satake, T; Tanaka, M | 1 |
Kommerell, B; Limberg, B | 1 |
Arai, I; Funo, S; Iizuka, A; Kase, Y; Kiuchi, N; Maeda, S; Ohkura, Y; Sudo, K; Takeda, S; Yoshida, C | 1 |
Takagi, D; Takeyama, N; Tanaka, T | 1 |
Brachtel, D; Wernze, H | 1 |
Ansari, RA; Aswal, BS; Chander, R; Dhawan, BN; Garg, NK; Kapoor, NK; Kulshreshtha, DK; Mehdi, H; Mehrotra, BN; Patnaik, GK | 1 |
Cai, ZH; O'Shea, GM; Shi, ZQ; Sun, AM | 1 |
Morimoto, Y; Tsuji, T; Ukida, M | 1 |
Miyata, M | 1 |
Hardy, MA; Kawai, Y; Price, JB | 1 |
Eto, T; Kajiyama, G; Nakamura, T; Nakanishi, T; Suemori, S; Yamada, K | 1 |
Fujiwara, K; Kuwata, S; Nishi, T; Nosaka, K; Ogata, I; Ohta, Y; Oka, H | 1 |
Li, BR; Wu, XM; Zhang, BG; Zhou, Q | 1 |
Dumont, JM; Maignan, MF; Perrissoud, D | 2 |
Grundmann, R; Koebe, HG; Waters, W | 1 |
Guo, SH; Zhang, DF; Zhou, YX | 1 |
Aburada, M; Arai, I; Fujii, Y; Funo, S; Hosoya, E; Kase, Y; Maemura, S; Ohkura, Y; Sudo, K; Takeda, S | 1 |
Chitranukroh, A; Kawata, S; McIntyre, N; Owen, JS | 1 |
Kobayashi, A; Sugata, F; Tsubomizu, Y | 1 |
Malchesky, PS; Nose, Y; Okabe, K; Sakamoto, H; Smith, JW; Takaoka, T; Tuthill, RJ; Usami, M | 1 |
Ernst, P; Marquet, R; ten Berg, RG; van Maldegem-Dronkers, C; Westbroek, DL | 1 |
Karagiulian, SR; Svanadze, NL | 1 |
Nagashima, H; Ukida, M; Usui, H | 1 |
Fujiwara, M; Hashimoto, M; Higashi, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Watanabe, A; Watanabe, M; Yamauchi, Y | 1 |
Siblíková, O; Trcka, V | 1 |
Baue, AE; Chaudry, IH; Clemens, MG; Hayashi, H; Ohkawa, M | 1 |
Cooksley, WG; Halliday, JW; Mack, U; Owens, J; Powell, LW | 1 |
Shinozuka, H | 1 |
Neupert, A; Petzold, H | 1 |
Rauen, HM; Schriewer, H | 1 |
Curtis, KJ; Kim, YS; Perdomo, J; Whitehead, JS | 1 |
Fujisawa, K; Okabe, K; Tanaka, K | 1 |
Boelcke, G; Erdmann, WD; Michelssen, A; Poser, W | 1 |
Hirner, A; Meyer-Burg, J | 1 |
9 review(s) available for galactosamine and Liver Diseases
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Calcium and the mechanisms of liver necrosis.
Topics: Animals; Calcium; Carbon Tetrachloride; Cell Membrane; Chemical and Drug Induced Liver Injury; Galactosamine; In Vitro Techniques; Liver; Liver Diseases; Necrosis; Phalloidine; Rats | 1982 |
Immunotoxicology of host-response-mediated experimental liver injury.
Topics: Animals; Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Galactosamine; Humans; Infections; Lipopolysaccharides; Liver Diseases; Tumor Necrosis Factor-alpha | 1994 |
[Role of endotoxins in renal changes during hepatopathies].
Topics: Acute Kidney Injury; Animals; Chemical and Drug Induced Liver Injury; Cholestasis; Diuresis; Endotoxins; Galactosamine; Guinea Pigs; Hemodynamics; Hepatitis; Humans; Kidney Diseases; Liver Cirrhosis; Liver Diseases; Osmolar Concentration; Rats; Water-Electrolyte Balance | 1978 |
[On the molecular mechanism of action of (+)-cyanidanol-3 (author's transl)].
Topics: Animals; Benzopyrans; Catechin; Chemical and Drug Induced Liver Injury; Galactosamine; Lipid Peroxides; Liver; Liver Diseases; Membranes; Phalloidine | 1979 |
Endotoxins in liver disease.
Topics: Animals; Endotoxins; Escherichia coli; Galactosamine; Humans; Liver; Liver Diseases; Mononuclear Phagocyte System; Rabbits; Rats; Salmonella | 1979 |
Mechanism and clinical relevance of elevated levels of circulating asialoglycoproteins.
Topics: Acute Disease; Animals; Asialoglycoproteins; Biomarkers; Chemical and Drug Induced Liver Injury; Chronic Disease; Disease Models, Animal; Galactosamine; Hepatitis; Humans; Liver Diseases; Liver Neoplasms, Experimental; Liver Regeneration | 1991 |
Animal models of fulminant hepatic failure.
Topics: Acetaminophen; Animals; Carbon Tetrachloride Poisoning; Disease Models, Animal; Galactosamine; Hepatectomy; Hepatic Artery; Hepatic Encephalopathy; Liver Diseases; Portacaval Shunt, Surgical | 1991 |
[Promotion of regeneration in extensive lesions of the liver (review of the literature)].
Topics: Adult; Animals; Dogs; Galactosamine; Growth Substances; Hepatectomy; Hepatic Encephalopathy; Humans; Liver; Liver Diseases; Liver Extracts; Liver Neoplasms; Liver Regeneration; Liver Transplantation; Male; Rats; Stimulation, Chemical | 1985 |
1 trial(s) available for galactosamine and Liver Diseases
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
241 other study(ies) available for galactosamine and Liver Diseases
Article | Year |
---|---|
Chemical inhibition of TRAF6-TAK1 axis as therapeutic strategy of endotoxin-induced liver disease.
Topics: Adaptor Proteins, Signal Transducing; Animals; Caspase 3; Cytokines; Endotoxins; Galactosamine; Ligases; Lipopolysaccharides; Liver Diseases; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; NF-kappa B; Protein Kinases; Receptors, Tumor Necrosis Factor; Signal Transduction; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; Ubiquitins | 2022 |
Blocking cGAS/STING signaling protects against sepsis-associated acute liver injury.
Topics: Animals; Galactosamine; Lipopolysaccharides; Liver; Liver Diseases; Membrane Proteins; Mice; Nucleotidyltransferases; Sepsis | 2022 |
Exopolysaccharides from
Topics: Animals; Bacteria; Female; Galactosamine; Gastrointestinal Microbiome; Humans; Lactobacillus; Lipopolysaccharides; Liver Diseases; Mice, Inbred BALB C; Polysaccharides, Bacterial | 2019 |
Activation of PKM2 metabolically controls fulminant liver injury via restoration of pyruvate and reactivation of CDK1.
Topics: Animals; Apoptosis; CDC2 Protein Kinase; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Pyridazines; Pyrroles; Pyruvate Kinase; Pyruvates; Pyruvic Acid | 2021 |
Elental® amino acid component has protective effects on primary cultured hepatocytes and a rat model of acute liver injury.
Topics: Acute Disease; Amino Acids; Animals; Cells, Cultured; Disease Models, Animal; Galactosamine; Hepatocytes; Interleukin-1beta; L-Lactate Dehydrogenase; Lipopolysaccharides; Liver; Liver Diseases; Male; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphatidylinositol 3-Kinase; Rats; Rats, Sprague-Dawley; Rats, Wistar; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |
Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota.
Topics: Animals; Bifidobacterium; Bifidobacterium pseudocatenulatum; Cytokines; Galactosamine; Gastrointestinal Microbiome; Inflammation Mediators; Intestinal Mucosa; Liver Diseases; Male; Metagenome; Metagenomics; Models, Biological; Rats | 2017 |
Coumarin Analogues from the Citrus grandis (L.) Osbeck and Their Hepatoprotective Activity.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Cell Line; Cell Survival; Citrus; Coumarins; Desiccation; Fruit; Galactosamine; Liver; Liver Diseases; Molecular Structure | 2019 |
Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
Topics: Alanine Transaminase; Animals; Apoptosis; Bile Acids and Salts; Bile Ducts; Biomarkers; Caspase 3; Cholestasis; Galactosamine; Hepatocytes; HMGB1 Protein; Inflammation; Keratin-18; Ligation; Liver; Liver Diseases; Mice; Mice, Inbred C57BL; MicroRNAs; Necrosis; Neutrophils | 2013 |
Hepatoprotective effect of limonin, a natural limonoid from the seed of Citrus aurantium var. bigaradia, on D-galactosamine-induced liver injury in rats.
Topics: Administration, Oral; Animals; Citrus; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Inflammation; Limonins; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Seeds; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Deletion of Mir155 prevents Fas-induced liver injury through up-regulation of Mcl-1.
Topics: Animals; Apoptosis; Base Sequence; Caspases; Cells, Cultured; Enzyme Activation; fas Receptor; Galactosamine; Gene Deletion; Gene Knockout Techniques; Hepatocytes; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Molecular Sequence Data; Myeloid Cell Leukemia Sequence 1 Protein; Protective Agents; Up-Regulation | 2015 |
Preparation and evaluation of luteolin-phospholipid complex as an effective drug delivery tool against GalN/LPS induced liver damage.
Topics: Animals; Drug Carriers; Female; Galactosamine; Inflammation; Lipopolysaccharides; Liver; Liver Diseases; Luteolin; Male; Phospholipids; Protective Agents; Rats; Rats, Wistar | 2016 |
Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Bifidobacterium; Cytokines; Dexamethasone; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Galactosamine; Gastrointestinal Microbiome; JNK Mitogen-Activated Protein Kinases; Lacticaseibacillus casei; Lipopolysaccharides; Liver; Liver Diseases; Male; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Probiotics; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 9 | 2016 |
Isofuranodiene, the main volatile constituent of wild celery (Smyrnium olusatrum L.), protects d-galactosamin/lipopolysacchride-induced liver injury in rats.
Topics: Alanine Transaminase; Animals; Apiaceae; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Crops, Agricultural; Furans; Galactosamine; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Liver Diseases; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Protective Agents; Rats; Rats, Sprague-Dawley | 2016 |
Kupffer-cell-expressed transmembrane TNF-α is a major contributor to lipopolysaccharide and D-galactosamine-induced liver injury.
Topics: Adoptive Transfer; Animals; Apoptosis; Cell Communication; Cell Membrane; Cytokines; Fas Ligand Protein; Galactosamine; Inflammation Mediators; Kupffer Cells; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice, Inbred C57BL; Transaminases; Tumor Necrosis Factor-alpha | 2016 |
Aqueous extract from Aconitum carmichaelii Debeaux reduces liver injury in rats via regulation of HMGB1/TLR4/NF-ΚB/caspase-3 and PCNA signaling pathways.
Topics: Aconitum; Animals; Caspase 3; Cysteine; Drug Combinations; Galactosamine; Glycine; Glycyrrhetinic Acid; HMGB1 Protein; Liver; Liver Diseases; Male; NF-kappa B; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4 | 2016 |
[Protective effect of Isodon lophanthoides on acute hepatic injury induced by D-galactosamine in rats].
Topics: Acute Disease; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Drugs, Chinese Herbal; Female; Galactosamine; Isodon; Liver; Liver Diseases; Liver Glycogen; Male; Plants, Medicinal; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley | 2008 |
Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice.
Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Caspase 8; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Enzyme Activation; Fas-Associated Death Domain Protein; Galactosamine; Gene Deletion; JNK Mitogen-Activated Protein Kinases; Liver Diseases; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Mutant Proteins; Necrosis; Phosphorylation | 2008 |
A novel fluorescent probe for the detection of nitric oxide in vitro and in vivo.
Topics: Animals; Chemical and Drug Induced Liver Injury; Copper; Disease Models, Animal; Endothelial Cells; Fluorescent Dyes; Galactosamine; Humans; Imidazoles; Lipopolysaccharides; Liver Diseases; Macrophages; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organometallic Compounds; Phenols; Time Factors | 2008 |
Mitochondrial modulation is involved in the hepatoprotection of Limonium sinense extract against liver damage in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blotting, Western; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Galactosamine; Lipopolysaccharides; Liver; Liver Diseases; Male; Medicine, Chinese Traditional; Membrane Potentials; Mice; Mice, Inbred ICR; Microscopy, Electron; Mitochondria, Liver; Plant Extracts; Plant Roots; Plumbaginaceae; Voltage-Dependent Anion Channels | 2008 |
Genetic delineation of the pathways mediated by bid and JNK in tumor necrosis factor-alpha-induced liver injury in adult and embryonic mice.
Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Embryo, Mammalian; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Diseases; MAP Kinase Kinase 4; Mice; Mice, Knockout; Mitochondria, Liver; Mitogens; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2009 |
Oxidant stress-induced liver injury in vivo: role of apoptosis, oncotic necrosis, and c-Jun NH2-terminal kinase activation.
Topics: Alanine Transaminase; Aldehydes; Animals; Antifibrinolytic Agents; Apoptosis; Caspases; Chemical and Drug Induced Liver Injury; Diquat; Disease Models, Animal; DNA Fragmentation; Endotoxins; Galactosamine; Glutathione Disulfide; Hepatocytes; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Liver Diseases; Male; Necrosis; Oxidative Stress; Rats; Rats, Inbred F344; Superoxides; Vitamin K 3 | 2009 |
Influence of alpha lipoic acid on antioxidant status in D-galactosamine-induced hepatic injury.
Topics: Analysis of Variance; Animals; Antioxidants; Biomarkers; Catalase; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Glutathione; Glutathione Peroxidase; Injections, Intraperitoneal; Lipid Peroxidation; Liver; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thioctic Acid | 2008 |
Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
Topics: Alanine Transaminase; Alkaloids; Animals; Aspartate Aminotransferases; Caffeine; Chemical and Drug Induced Liver Injury; Chlorogenic Acid; Coffee; Galactosamine; Interleukin-10; Lipopolysaccharides; Liver Diseases; Male; Niacin; Pyrazinamide; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2009 |
Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice.
Topics: Acetaminophen; Administration, Oral; Alpha-Amanitin; Animals; Chemical and Drug Induced Liver Injury; Fructose; Galactosamine; Glucose; Interleukin-10; Intestinal Mucosa; Lipopolysaccharides; Liver Diseases; Mice; Mice, Inbred C57BL; Signal Transduction; Sodium-Glucose Transporter 1; Sucrose; Toll-Like Receptor 4 | 2009 |
Lactobacillus casei: influence on the innate immune response and haemostatic alterations in a liver-injury model.
Topics: Animals; Blood Cell Count; Chemical and Drug Induced Liver Injury; Galactosamine; Immunity, Innate; Lacticaseibacillus casei; Liver; Liver Diseases; Mice; Mice, Inbred BALB C; Models, Biological; Probiotics | 2009 |
Effects of gut microflora on hepatic damage after acute liver injury in rats.
Topics: Animals; Bacterial Translocation; Chemical and Drug Induced Liver Injury; Cytokines; Endotoxins; Escherichia coli; Galactosamine; Gentamicins; Intestinal Mucosa; Intestines; Kidney; Liver; Liver Diseases; Lymph Nodes; Male; Mesentery; Peyer's Patches; Probiotics; Rats; Rats, Sprague-Dawley; Salmonella enteritidis; Spleen | 2010 |
Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways.
Topics: Animals; Apoptosis; Benzofurans; Cell Line; DNA; DNA Fragmentation; Electrophoresis, Agar Gel; Flow Cytometry; Galactosamine; Hepatocytes; Humans; Inflammation; Lipopolysaccharides; Liver Diseases; Liver Function Tests; Male; Mice; Mitochondria; Receptors, Death Domain; Signal Transduction; Tumor Necrosis Factor-alpha | 2010 |
Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases.
Topics: Adult; Alanine Transaminase; Animals; Biomarkers; Chemical and Drug Induced Liver Injury; Ethanol; Female; Galactosamine; Hepatitis B, Chronic; Humans; Liver Diseases; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Muscle, Skeletal; Plasma | 2010 |
Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFκB pathways.
Topics: Animals; Antioxidants; Apoptosis; Disease Models, Animal; Galactosamine; Gene Expression Regulation; Hepatocytes; Inflammation; Liver Diseases; Male; Mangifera; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Oxidative Stress; Rats; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Xanthones | 2012 |
Suppression of lipopolysaccharide and galactosamine-induced hepatic inflammation by red grape pomace.
Topics: Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Down-Regulation; Galactosamine; Humans; Industrial Waste; Lipopolysaccharides; Liver; Liver Diseases; Male; Nitric Oxide Synthase; Plant Extracts; Rats; Rats, Sprague-Dawley; Vitis | 2012 |
A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage.
Topics: Acute Disease; Adenoviridae; Animals; Cell Nucleus; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Drug Combinations; Female; Galactosamine; Gene Expression; Hepacivirus; Liver Diseases; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Recombination, Genetic; Transduction, Genetic; Tumor Necrosis Factor-alpha; Viral Core Proteins; Viral Envelope Proteins | 2003 |
Hepatoprotective effect of myristicin from nutmeg (Myristica fragrans) on lipopolysaccharide/d-galactosamine-induced liver injury.
Topics: Alanine Transaminase; Allylbenzene Derivatives; Animals; Aspartate Aminotransferases; Benzyl Compounds; Chemical and Drug Induced Liver Injury; Diet; Dioxolanes; DNA Fragmentation; Galactosamine; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Myristica; Oils, Volatile; Pyrogallol; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2003 |
Glycosmis arborea extract as a hepatoprotective agent.
Topics: Acetaminophen; Alanine Transaminase; Alkaline Phosphatase; Animals; Body Weight; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Galactosamine; Lethal Dose 50; Lipid Peroxidation; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Rutaceae; Superoxide Dismutase; Survival Rate; Toxicity Tests, Acute | 2003 |
STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury.
Topics: Animals; Apoptosis; Cell Line; Chemical and Drug Induced Liver Injury; DNA Fragmentation; DNA-Binding Proteins; Flow Cytometry; Galactosamine; Hepatocytes; Interferon-gamma; Lipopolysaccharides; Liver Diseases; Mice; Mice, Inbred BALB C; Mice, Knockout; Phosphorylation; Phosphotyrosine; STAT1 Transcription Factor; Trans-Activators; Transfection; Tumor Necrosis Factor-alpha | 2003 |
Glycine modulates cytokine secretion, inhibits hepatic damage and improves survival in a model of endotoxemia in mice.
Topics: Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; Cells, Cultured; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Endotoxemia; Escherichia coli; Galactosamine; Glycine; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Liver Diseases; Mice; Mice, Inbred BALB C; Survival Rate | 2003 |
Silibinin protects mice from T cell-dependent liver injury.
Topics: Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Cytoprotection; Enzyme Induction; Galactosamine; Leukocytes; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Recombinant Proteins; RNA, Messenger; Silybin; Silymarin; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2003 |
Serum-galactosamine. A diagnostic index of liver fibrosis in liver disease.
Topics: Amino Sugars; Galactosamine; Humans; Liver Cirrhosis; Liver Diseases; Vascular Diseases | 1961 |
Hepatocyte isolation and transplantation in the pig.
Topics: Animals; Cell Separation; Cell Survival; Cell Transplantation; Collagenases; Disease Models, Animal; Endopeptidases; Galactosamine; Hepatocytes; Liver Diseases; Liver Failure, Acute; Liver Transplantation; Male; Perfusion; Survival Rate; Sus scrofa; Transplantation, Heterologous; Treatment Outcome | 2003 |
Suppression by Hydrangeae Dulcis Folium of D-galactosamine-induced liver injury in vitro and in vivo.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Hydrangea; Liver; Liver Diseases; Phytotherapy; Plant Extracts; Rats; Rats, Wistar | 2003 |
Ingestion of resistant starch protects endotoxin influx from the intestinal tract and reduces D-galactosamine-induced liver injury in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Endotoxins; Galactosamine; Intestines; Liver Diseases; Male; Portal Vein; Rats; Rats, Wistar; Starch; Transaminases | 2004 |
Effect of dietary enrichment with n-3 polyunsaturated fatty acids (PUFA) or n-9 PUFA on arachidonate metabolism in vivo and experimentally induced inflammation in mice.
Topics: Acute Disease; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cyclooxygenase Inhibitors; Diet; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Female; Freund's Adjuvant; Galactosamine; Granuloma; Inflammation; Leukocyte Count; Lipids; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Peritoneal Cavity; Prostaglandin-Endoperoxide Synthases; Triglycerides | 2004 |
[Protective effect of curcumin on experimental liver injury in mice].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Curcumin; Galactosamine; Lipopolysaccharides; Liver; Liver Diseases; Male; Malondialdehyde; Mice; Nitric Oxide; Protective Agents | 2003 |
[A comparison of the protective activity of liver injury induced by D-galact-osamine between huangqin-tang and their metabolites by human intestinal bacteria].
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bacteria; Chemical and Drug Induced Liver Injury; Drugs, Chinese Herbal; Galactosamine; Intestines; Liver Diseases; Male; Mice; Plants, Medicinal; Protective Agents | 2003 |
High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice.
Topics: Adjuvants, Immunologic; Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Female; Galactosamine; Hyaluronic Acid; Infusions, Intravenous; Lipopolysaccharides; Liver Diseases; Male; Mice; Models, Animal; Molecular Weight; T-Lymphocytes | 2004 |
Liver dysfunction induced by bile duct ligation and galactosamine injection alters cardiac protein synthesis.
Topics: Algorithms; Animals; Bile Ducts; Chemical and Drug Induced Liver Injury; DNA; Galactosamine; Kinetics; Ligation; Liver Diseases; Male; Malnutrition; Myocardium; Organ Size; Phenylalanine; Protein Biosynthesis; Rats; Rats, Wistar; RNA | 2004 |
A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Galactosamine; Galactosylceramides; In Situ Nick-End Labeling; Interferon-gamma; Killer Cells, Natural; Liver; Liver Diseases; Mice; Mice, Knockout; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2005 |
Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity.
Topics: Animals; Apoptosis; Blotting, Western; Caspases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endotoxins; Enzyme-Linked Immunosorbent Assay; Galactosamine; Gene Expression; Interleukin-8; Liver; Liver Diseases; Male; Mice; Mice, Transgenic; NF-kappa B; RNA, Messenger; Transgenes; Tumor Necrosis Factor-alpha | 2006 |
Lack of protective effect of D-003, a mixture of high-molecular-weight primary acids from sugar cane wax, on liver damage induced by galactosamine in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Fatty Acids; Galactosamine; Hepatocytes; Inclusion Bodies; Lipids; Liver Diseases; Male; Necrosis; Rats; Rats, Sprague-Dawley | 2005 |
In vivo antihepatotoxic effects of Ligularia fischeri var. spiciformis and the identification of the active component, 3,4-dicaffeoylquinic acid.
Topics: 1-Naphthylisothiocyanate; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Asteraceae; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chlorogenic Acid; Ethionine; Fatty Liver; Galactosamine; gamma-Glutamyltransferase; L-Iditol 2-Dehydrogenase; L-Lactate Dehydrogenase; Lipids; Liver; Liver Diseases; Male; Plant Leaves; Rats; Rats, Sprague-Dawley | 2005 |
Hepatoprotection of D-galactosamine-induced toxicity in mice by purified fractions from Garcinia kola seeds.
Topics: Animals; Chemical and Drug Induced Liver Injury; Flavonoids; Galactosamine; Garcinia kola; Glucose-6-Phosphatase; Glutathione; Lipid Peroxidation; Liver; Liver Diseases; Male; Mice; Microsomes, Liver; Protective Agents; Seeds; Transferases | 2006 |
S-adenosylmethionine but not glutathione protects against galactosamine-induced cytotoxicity in rat hepatocyte cultures.
Topics: Animals; Cells, Cultured; Galactosamine; Glutathione; Hepatocytes; L-Lactate Dehydrogenase; Liver Diseases; Male; Maleates; Rats; Rats, Long-Evans; S-Adenosylmethionine | 2006 |
Hepatoprotective effects of purple potato extract against D-galactosamine-induced liver injury in rats.
Topics: Animals; Appetite; Body Weight; Chemical and Drug Induced Liver Injury; Color; Galactosamine; Glutathione; Lipid Peroxidation; Liver; Liver Diseases; Male; Nitric Oxide; Organ Size; Plant Extracts; Rats; Solanum tuberosum; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2006 |
A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats.
Topics: Aniline Compounds; Animals; Chemical and Drug Induced Liver Injury; Clofibrate; Galactosamine; Liver; Liver Diseases; Metabolic Networks and Pathways; Rats; Urine | 2006 |
Red potato extract protects from D-galactosamine-induced liver injury in rats.
Topics: Alanine Transaminase; Animals; Anthocyanins; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Galactosamine; Glutathione; L-Lactate Dehydrogenase; Liver Diseases; Male; Plant Extracts; Random Allocation; Rats; Rats, Inbred F344; Solanum tuberosum; Thiobarbituric Acid Reactive Substances | 2006 |
Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury.
Topics: alpha-Fetoproteins; Animals; Carbon Tetrachloride; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Galactosamine; Hepatectomy; Hepatocytes; Liver Diseases; Liver Neoplasms, Experimental; Liver Regeneration; Male; Mice; Nitrosamines; Rats; Stem Cells | 2006 |
Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cytokines; Galactosamine; Glycyrrhizic Acid; Lipopolysaccharides; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Protective Agents | 2007 |
Effects of various kinds of edible seaweeds in diets on the development of D-galactosamine-induced hepatopathy in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Carboxylic Acids; Cecum; Chemical and Drug Induced Liver Injury; Dietary Fiber; Galactosamine; Glutathione; Hydro-Lyases; Liver Diseases; Male; Rats; Rats, Wistar; Seaweed | 2007 |
Galactosamine-induced acute liver injury in rats reduces hepatic alpha-tocopherol transfer protein production.
Topics: Alanine Transaminase; alpha-Tocopherol; Animals; Aspartate Aminotransferases; Blotting, Western; Carrier Proteins; Chemical and Drug Induced Liver Injury; Cholesterol; Disease Models, Animal; Galactosamine; L-Lactate Dehydrogenase; Liver Diseases; Male; Phospholipids; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triglycerides | 2007 |
Effect of dietary fiber in edible seaweeds on the development of D-galactosamine-induced hepatopathy in rats.
Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Body Weight; Cecum; Chemical and Drug Induced Liver Injury; Dietary Fiber; Disease Models, Animal; Galactosamine; Intestines; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Neomycin; Rats; Rats, Wistar; Seaweed | 2007 |
Significantly greater antioxidant anticancer activities of 2,3-dehydrosilybin than silybin.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Galactosamine; Hepatocytes; Humans; Hydrogen Peroxide; Keratinocytes; Liver Diseases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Molecular Structure; Reactive Oxygen Species; Silybin; Silymarin | 2008 |
Preventive effect of ethanol extract of Phyllanthus rheedii Wight. on D-galactosamine induced hepatic damage in Wistar rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Ethanol; Female; Galactosamine; Gene Expression Regulation; Liver; Liver Diseases; Male; Phyllanthus; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice.
Topics: Acute Disease; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Down-Regulation; Galactosamine; Glycyrrhizic Acid; Immunohistochemistry; Injections, Intraperitoneal; Injections, Intravenous; Lipopolysaccharides; Liver; Liver Diseases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2008 |
Superiority of serum type-I arginase and ornithine carbamyltransferase in the detection of toxicant-induced acute hepatic injury in rats.
Topics: Alanine Transaminase; Animals; Arginase; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Concanavalin A; Galactosamine; Lipopolysaccharides; Liver Diseases; Liver Function Tests; Male; Ornithine Carbamoyltransferase; Propanols; Rats; Rats, Wistar | 2008 |
Protective effects of amide constituents from the fruit of Piper chaba on D-galactosamine/TNF-alpha-induced cell death in mouse hepatocytes.
Topics: Alanine Transaminase; Alkaloids; Amides; Animals; Aspartate Aminotransferases; Benzodioxoles; Cell Death; Chromatography, High Pressure Liquid; Fruit; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Mice, Mutant Strains; Molecular Structure; Piperaceae; Piperidines; Plant Extracts; Polyunsaturated Alkamides; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2008 |
Protective effects of pirfenidone on D-galactosamine and lipopolysaccharide-induced acute hepatotoxicity in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Inflammation; Lipid Peroxidation; Lipopolysaccharides; Liver; Liver Diseases; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Pyridones; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2008 |
Combination of selenium and three naturally occurring antioxidants administration protects D-galactosamine-induced liver injury in rats.
Topics: alpha-Tocopherol; Animals; Antioxidants; Apoptosis; Ascorbic Acid; beta Carotene; Caspase 3; Cell Proliferation; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Galactosamine; Immunohistochemistry; In Situ Nick-End Labeling; Liver; Liver Diseases; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Selenium | 2008 |
Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2.
Topics: Animals; Cell Death; Cell Line; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Susceptibility; Galactosamine; Humans; Intracellular Space; Lipopolysaccharides; Liver Diseases; Mice; Mice, Transgenic; Neutralization Tests; Protein Isoforms; Receptors, Tumor Necrosis Factor, Type II; Solubility; Tumor Necrosis Factor-alpha | 2008 |
Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalN.
Topics: Animals; Blood Coagulation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Galactosamine; Lipopolysaccharides; Liver; Liver Diseases; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Count; Time Factors | 2008 |
Walnut polyphenols prevent liver damage induced by carbon tetrachloride and d-galactosamine: hepatoprotective hydrolyzable tannins in the kernel pellicles of walnut.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Flavonoids; Galactosamine; Gallic Acid; Glucosides; Hydrolysis; Juglans; Liver Diseases; Phenols; Polyphenols; Rats; Seeds; Tannins | 2008 |
The pattern of D-galactosamine-induced hepatocellular injury modified by simultaneous application of D (--)-fructose.
Topics: Animals; Chemical and Drug Induced Liver Injury; Fructose; Galactosamine; Liver; Liver Diseases; Male; Microscopy, Electron; Rats; Rats, Inbred Strains; Time Factors | 1981 |
Influence of D-galactosamine and alpha-naphthylisothiocyanate on the activities of some intestinal enzymes.
Topics: 1-Naphthylisothiocyanate; 5'-Nucleotidase; Alanine Transaminase; Alkaline Phosphatase; alpha-Glucosidases; Animals; Aspartate Aminotransferases; beta-Galactosidase; Bilirubin; Galactosamine; gamma-Glutamyltransferase; Intestinal Mucosa; Jejunum; Liver Diseases; Male; Nucleotidases; Rats; Rats, Inbred Strains; Sucrase; Thiocyanates | 1984 |
Clinical and experimental studies on the profiles of serum proteins in acute hepatic injury.
Topics: Acute Disease; Adolescent; Adult; Aged; alpha 1-Antitrypsin; alpha-2-HS-Glycoprotein; Animals; Beta-Globulins; Blood Proteins; Female; Galactosamine; Haptoglobins; Hepatitis; Humans; Liver Diseases; Male; Mice; Middle Aged; Prealbumin; Rats; Rats, Inbred Strains; Time Factors | 1981 |
Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D-galactosamine-induced liver failure in rats.
Topics: Acute Disease; Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Galactosamine; In Vitro Techniques; Liver; Liver Diseases; Liver Transplantation; Male; Rats; Rats, Inbred F344; Spleen; Transplantation, Isogeneic | 1983 |
Zinc content in liver of experimental fulminant hepatic failure rat.
Topics: Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Glucagon; Insulin; Liver Diseases; Liver Regeneration; Male; Rats; Rats, Inbred Strains; Zinc | 1983 |
The mechanism of hepatoprotection by epsilon aminocaproic acid and putrescine.
Topics: Aminocaproates; Aminocaproic Acid; Animals; Chemical and Drug Induced Liver Injury; Eflornithine; Galactosamine; Liver Diseases; Necrosis; Ornithine; Ornithine Decarboxylase Inhibitors; Protease Inhibitors; Putrescine; Rats; Rats, Inbred Strains; Urokinase-Type Plasminogen Activator | 1984 |
Function of trace metal in experimental fulminant hepatic failure--special reference to variation in zinc content in liver.
Topics: Acute Disease; Animals; Dogs; Galactosamine; Ischemia; Liver; Liver Diseases; Male; Rats; Trace Elements; Zinc | 1984 |
Efficacies of whole blood and plasma cross circulation on galactosamine induced hepatic failure rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cross Circulation; Galactosamine; Liver Diseases; Liver Function Tests; Male; Parabiosis; Plasma; Rats; Rats, Inbred Strains | 1984 |
[Alterations in hepatic high-energy metabolism in galactosamine-induced acute hepatic failure in rabbits].
Topics: Acute Disease; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Energy Metabolism; Galactosamine; Liver; Liver Diseases; Mitochondria, Liver; Rabbits | 1984 |
Activation of tubuloglomerular feedback in rat nephrons by sera from rabbits with fulminant hepatic failure.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dialysis; Feedback; Female; Galactosamine; Glomerular Filtration Rate; Kidney Glomerulus; Kidney Tubules; Liver Diseases; Male; Perfusion; Rabbits; Rats; Rats, Inbred Strains | 1983 |
[70% hepatectomy and portacaval termino-lateral anastomosis as an experimental model of fulminating hepatic insufficiency].
Topics: Animals; Galactosamine; Hepatectomy; Hepatic Artery; Ligation; Liver Diseases; Male; Portacaval Shunt, Surgical; Rats; Rats, Inbred Strains; Thioacetamide | 1983 |
Analysis of hepatic failure plasma by high performance gel-chromatography.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromatography, Gel; Dogs; Galactosamine; Liver Diseases; Male; Molecular Weight; Rats; Rats, Inbred Strains | 1983 |
Enzymes of cerebral GABA metabolism and synaptosomal GABA uptake in acute liver failure in the rabbit: evidence for decreased cerebral GABA-transaminase activity.
Topics: 4-Aminobutyrate Transaminase; Animals; Cerebral Cortex; Galactosamine; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Kinetics; Liver Diseases; Rabbits; Synaptosomes | 1984 |
Factors effective in reducing rat mortality due to acute liver failure as induced by D-galactosamine poisoning.
Topics: Acute Disease; Animals; Cells, Cultured; Chromatography, Gel; Cytosol; Galactosamine; Hepatectomy; Liver Diseases; Liver Regeneration; Male; Neuraminidase; Rats; Rats, Inbred F344 | 1984 |
Cystamine modulation of galactosamine-induced hepatotoxicity.
Topics: Animals; Calcium; Chemical and Drug Induced Liver Injury; Cystamine; Dose-Response Relationship, Drug; Galactosamine; Liver; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains; Uridine | 1984 |
Effects of homologous plasma cross-circulation on liver function in galactosamine-induced hepatic necrosis in rats.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cross Circulation; Galactosamine; Liver Diseases; Liver Function Tests; Male; Mitochondria, Liver; Necrosis; Parabiosis; Plasma Exchange; Rats; Rats, Inbred Strains | 1984 |
[Long-term cross-circulation on galactosamine induced hepatic failure rats].
Topics: Animals; Chemical and Drug Induced Liver Injury; Cross Circulation; Galactosamine; Liver Diseases; Liver Regeneration; Male; Mitochondria, Liver; Parabiosis; Rats; Rats, Inbred Strains | 1984 |
[Homologous plasma cross-circulation on galactosamine induced hepatic failure rats].
Topics: Animals; Chemical and Drug Induced Liver Injury; Cross Circulation; Galactosamine; Liver Diseases; Male; Parabiosis; Plasmapheresis; Rats; Rats, Inbred Strains | 1984 |
Tyrosinase immobilized within artificial cells for detoxification in liver failure: II. In vivo studies in fulminant hepatic failure rats.
Topics: Animals; Catechol Oxidase; Chemical and Drug Induced Liver Injury; Enzymes, Immobilized; Galactosamine; Hemoperfusion; Inactivation, Metabolic; Liver Diseases; Male; Monophenol Monooxygenase; Rats; Rats, Inbred Strains; Tyrosine | 1981 |
[Preliminary observations on D-galactosamine-induced hepatic failure in rat models (author's transl)].
Topics: Animals; Bilirubin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Diseases; Rats | 1981 |
The protective effect of polyriboinosinic acid-polyribocytidylic acid against the occurrence of galactosamine-induced liver cell injury in rat.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carboxymethylcellulose Sodium; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Male; Methylcellulose; Necrosis; Peptides; Poly I-C; Polylysine; Rats; Rats, Inbred Strains | 1983 |
Increased blood-brain transfer in a rabbit model of acute liver failure.
Topics: Aminoisobutyric Acids; Animals; Autoradiography; Biological Transport, Active; Blood-Brain Barrier; Capillary Permeability; Carbon Radioisotopes; Chemical and Drug Induced Liver Injury; Galactosamine; Hepatic Encephalopathy; Liver Diseases; Rabbits | 1983 |
Modulation of galactosamine-induced liver injury by some amino acids or Triton WR1339.
Topics: Amino Acids; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Isocitrate Dehydrogenase; Liver Diseases; Male; Necrosis; Polyethylene Glycols; Rats; Rats, Inbred Strains | 1983 |
Sensitivity of serum glutamic oxaloacetic transaminase and bile acid levels for the detection of experimental liver injury in rats.
Topics: Animals; Aspartate Aminotransferases; Bile Acids and Salts; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Disease Models, Animal; Galactosamine; Liver Diseases; Male; Rats; Rats, Inbred Strains | 1981 |
Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Chemical and Drug Induced Liver Injury; Galactosamine; Hepatic Artery; Ligation; Liver; Liver Diseases; Liver Transplantation; Male; Peritoneal Cavity; Rats; Rats, Inbred Lew; Swine; Tissue Preservation; Transplantation, Heterologous; Transplantation, Homologous; Transplantation, Isogeneic | 1980 |
Reversal of experimental acute hepatic failure in the rat.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Liver; Liver Diseases; Liver Transplantation; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic | 1980 |
Cellular transplantation in the treatment of experimental hepatic failure.
Topics: Animals; Bone Marrow Transplantation; Disease Models, Animal; Galactosamine; Hepatectomy; Hypoxia; Liver; Liver Diseases; Liver Transplantation; Necrosis; Rats; Transplantation, Homologous | 1980 |
Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytosol; Female; Galactosamine; Graft Enhancement, Immunologic; Liver; Liver Diseases; Liver Regeneration; Liver Transplantation; Male; Rabbits; Rats; Swine; Thymidine; Transplantation, Heterologous; Transplantation, Homologous; Tritium | 1981 |
Endotoxin-induced hyperinsulinemia and hyperglucagonemia after experimental liver injury.
Topics: Animals; Carbon Tetrachloride Poisoning; Disease Models, Animal; Endotoxins; Galactosamine; Glucagon; Hepatectomy; Hyperinsulinism; Liver Diseases; Male; Rats; Salmonella enteritidis | 1981 |
Insulin and glucagon concentrations in the portal and peripheral blood in liver-injured and partially hepatectomized rats.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Galactosamine; Glucagon; Hepatectomy; Insulin; Jugular Veins; Liver Diseases; Liver Regeneration; Male; Portal Vein; Rats; Rats, Inbred Strains | 1982 |
The sequence of changes in the biosynthesis of sulfated glycosaminoglycans in acute, experimental liver disease.
Topics: Animals; Chemical and Drug Induced Liver Injury; Enzymes; Galactosamine; Glycosaminoglycans; Glycosides; Liver Cirrhosis, Experimental; Liver Diseases; Male; Phosphoadenosine Phosphosulfate; Protein Biosynthesis; Rats; Rats, Inbred Strains; Thioacetamide | 1982 |
Cell-free supernatant from hepatocyte cultures improves survival of rats with chemically induced acute liver failure.
Topics: Acute Disease; Animals; Cell Extracts; Cells, Cultured; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Male; Microscopy, Electron; Rats; Rats, Inbred F344; Tissue Extracts | 1982 |
[Modelling of acute liver failure in rabbits].
Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Diseases; Rabbits; Time Factors | 1982 |
Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats.
Topics: Animals; Asialoglycoproteins; Carrier Proteins; Chemical and Drug Induced Liver Injury; Galactosamine; Glycoproteins; Lectins; Liver Diseases; Male; Microsomes, Liver; Orosomucoid; Rats; Receptors, Cell Surface | 1981 |
Raised serum biliverdin in hepatic necrosis.
Topics: Acetaminophen; Animals; Bile Acids and Salts; Bilirubin; Biliverdine; Chemical and Drug Induced Liver Injury; Cholestasis; Galactosamine; Humans; Liver; Liver Diseases; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Rats | 1981 |
Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.
Topics: Animals; Chemical and Drug Induced Liver Injury; Disaccharides; Endotoxins; Galactosamine; Infusions, Parenteral; Lactulose; Liver; Liver Diseases; Rats | 1981 |
Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; DNA; Drug Tolerance; Galactosamine; Humans; Interleukin-1; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Necrosis; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Nitroprusside; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1995 |
[Liver-protecting and alanine aminotransferase lowering actions of hongning gantai].
Topics: Alanine Transaminase; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Drug Combinations; Drugs, Chinese Herbal; Female; Galactosamine; Liver; Liver Diseases; Male; Mice; Rats; Rats, Sprague-Dawley | 1995 |
Transplantation of microencapsulated hepatocytes for liver function replacement.
Topics: Animals; Artificial Organs; Biodegradation, Environmental; Cell Membrane Permeability; Cell Survival; Cell Transplantation; Cryopreservation; Disease Models, Animal; Drug Compounding; Galactosamine; Hepatic Encephalopathy; Immunosuppression Therapy; Liver; Liver Diseases; Liver Function Tests; Male; Rats; Rats, Wistar | 1995 |
Role of acute-phase proteins in interleukin-1-induced nonspecific resistance to bacterial infections in mice.
Topics: Acute-Phase Proteins; Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Fibrinogen; Galactosamine; Homeostasis; Immunity, Innate; Interleukin-1; Interleukin-6; Klebsiella Infections; Klebsiella pneumoniae; Liver Diseases; Mice; Pseudomonas Infections | 1993 |
Synthesis and pharmacological activities of novel bicyclic thiazoline derivatives as hepatoprotective agents II. (7-Alkoxycarbonyl-2,3,5,6-tetrahydropyrrolo[2,1-b]thiazol-3-ylidend) acetamid derivatives.
Topics: Animals; Antibodies, Monoclonal; Bridged Bicyclo Compounds; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Mice; Rats; Structure-Activity Relationship; Thiazoles | 1995 |
The evaluation of hepatoprotective effects of Taiwan folk medicine 'teng-khia-u'.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Cell Division; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Diseases; Lymphocytes; Male; Medicine, Traditional; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Taiwan | 1995 |
Serum hepatocyte growth factor levels in liver diseases: clinical implications.
Topics: Adult; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Galactosamine; Hepatocyte Growth Factor; Humans; Immunoradiometric Assay; Liver; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Prognosis; Reference Values; RNA, Messenger | 1995 |
Effect of pretreatment of rats with uracil on liver injuries induced by D-galactosamine and allyl alcohol.
Topics: 1-Propanol; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Male; Propanols; Rats; Rats, Wistar; Uracil | 1994 |
Protective action of putrescine against rat liver injury.
Topics: Administration, Oral; Animals; Carbon Tetrachloride Poisoning; Cell Membrane; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Galactosamine; Lipid Peroxidation; Liver; Liver Diseases; Male; Octoxynol; Peroxides; Putrescine; Rats; Rats, Sprague-Dawley; tert-Butylhydroperoxide | 1994 |
Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats.
Topics: Animals; Bacterial Toxins; Disseminated Intravascular Coagulation; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Galactosamine; Intestinal Diseases; Lipopolysaccharides; Liver Diseases; Lung Diseases; Male; Necrosis; Rats; Rats, Sprague-Dawley; Shock, Septic; Tumor Necrosis Factor-alpha | 1994 |
Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease.
Topics: Animals; Carbon Tetrachloride; Chemokine CCL2; Chemotactic Factors; Cytokines; Galactosamine; Gene Expression; Humans; Lipopolysaccharides; Liver; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; RNA, Messenger | 1994 |
Pharmacokinetics of indocyanine green in rats with experimentally induced hepatic diseases.
Topics: Acute Disease; Animals; Bile; Blood Proteins; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cholestasis; Galactosamine; Indocyanine Green; Liver; Liver Circulation; Liver Diseases; Male; Metabolic Clearance Rate; Rats; Rats, Wistar | 1993 |
Prevention of galactosamine-induced hepatic damage by picroliv: study on bile flow and isolated hepatocytes (ex vivo).
Topics: Animals; Bile; Chemical and Drug Induced Liver Injury; Cinnamates; Female; Galactosamine; Glycosides; In Vitro Techniques; Liver Diseases; Male; Plant Extracts; Rats; Silymarin; Vanillic Acid | 1993 |
The effect of endotoxin and Lactobacillus pretreatment on peritoneal macrophage behavior in acute liver injury in rat.
Topics: Animals; Calorimetry; Chemical and Drug Induced Liver Injury; Endotoxins; Free Radicals; Galactosamine; Hot Temperature; Lactobacillus; Liver; Liver Diseases; Luminescent Measurements; Macrophages, Peritoneal; Male; Phagocytosis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 1996 |
Expression of heparin-binding EGF-like growth factor in rat liver injured by carbon tetrachloride or D-galactosamine.
Topics: Animals; Blotting, Western; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Epidermal Growth Factor; Galactosamine; Gene Expression; Heparin; Liver; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1996 |
Differential effects of malnutrition, bile duct ligation and galactosamine injection in young rats on serum levels and gene expression of IGF-binding proteins.
Topics: Animals; Base Sequence; Bile Ducts; Blotting, Northern; Disease Models, Animal; DNA Primers; Galactosamine; Gene Expression; Immunoblotting; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Ligation; Liver; Liver Diseases; Male; Molecular Sequence Data; Nutrition Disorders; Polymerase Chain Reaction; Rats; Rats, Wistar | 1996 |
Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice.
Topics: Animals; Cell Adhesion Molecules; Chemical and Drug Induced Liver Injury; Galactosamine; Immunization; Immunohistochemistry; Interleukin-10; Lipopolysaccharides; Liver; Liver Diseases; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Tumor Necrosis Factor-alpha | 1996 |
Pharmacokinetics of glycyrrhizin in rats with D-galactosamine-induced hepatic disease.
Topics: Administration, Oral; Animals; Antiviral Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Gastric Emptying; Glycyrrhetinic Acid; Glycyrrhizic Acid; Injections, Intravenous; Intestinal Absorption; Liver Diseases; Male; Rats; Rats, Wistar | 1996 |
Immunohistochemical study of proteoglycans in D-galactosamine-induced acute liver injury in rats.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Dermatan Sulfate; Disease Models, Animal; Extracellular Matrix; Galactosamine; Heparitin Sulfate; Immunohistochemistry; Liver; Liver Diseases; Male; Microscopy, Electron; Proliferating Cell Nuclear Antigen; Proteoglycans; Rats; Rats, Sprague-Dawley | 1996 |
Protective effect of celosian, an acidic polysaccharide, on chemically and immunologically induced liver injuries.
Topics: Animals; Bilirubin; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Enzymes; Galactosamine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Lipid Peroxidation; Lipid Peroxides; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Necrosis; Plant Extracts; Polysaccharides; Rats; Rats, Sprague-Dawley; Seeds; Tumor Necrosis Factor-alpha | 1996 |
The effect of pretreatment with endotoxin and lactobacillus on bacterial translocation in acute liver injury.
Topics: Animals; Bacterial Translocation; Chemical and Drug Induced Liver Injury; Endotoxins; Galactosamine; Lactobacillus; Liver Diseases; Rats; Rats, Sprague-Dawley | 1996 |
Effects of dietary gluten on the hepatotoxic action of galactosamine and/or endotoxin in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Caseins; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Endotoxins; Galactosamine; Glutens; L-Lactate Dehydrogenase; Liver Diseases; Male; Rats; Rats, Wistar | 1996 |
Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro.
Topics: Animals; Biomarkers; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Cells, Cultured; Clenbuterol; Galactosamine; Glutathione; Ketones; Liver; Liver Diseases; Male; Maleates; Necrosis; Phenobarbital; Rats; Rats, Sprague-Dawley; Taurine; Thioacetamide | 1996 |
Effect of dietary L-glutamine on the hepatotoxic action of D-galactosamine in rats.
Topics: Alanine; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Diet; Galactosamine; Glutamic Acid; Glutamine; L-Lactate Dehydrogenase; Liver Diseases; Male; Neomycin; Rats; Rats, Wistar; Stereoisomerism | 1996 |
Cholesteryl hemisuccinate treatment protects rodents from the toxic effects of acetaminophen, adriamycin, carbon tetrachloride, chloroform and galactosamine.
Topics: Acetaminophen; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chloroform; Cholesterol Esters; Doxorubicin; Galactosamine; Heart Diseases; Liver Diseases; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley | 1997 |
Inhibition of nitric oxide modulates the effect of oral arginine supplementation in acute liver injury.
Topics: Acute Disease; Administration, Oral; Alanine Transaminase; Analysis of Variance; Animals; Arginine; Aspartate Aminotransferases; Bacterial Translocation; Bilirubin; Chemical and Drug Induced Liver Injury; Colony Count, Microbial; Disease Models, Animal; DNA; Enzyme Inhibitors; Food, Fortified; Galactosamine; Intestinal Mucosa; Liver Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; RNA | 1997 |
Apoptosis of murine hepatocytes induced by high doses of galactosamine.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; DNA Fragmentation; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Galactosamine; Histocytochemistry; Injections, Intraperitoneal; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Necrosis; Time Factors | 1997 |
Comparative study of oral and parenteral administration of sho-saiko-to (xiao-chaihu-tang) extract on D-galactosamine-induced liver injury in rats.
Topics: 5'-Nucleotidase; Administration, Oral; Animals; Biomarkers; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drugs, Chinese Herbal; Galactosamine; Glucose-6-Phosphatase; Hypolipidemic Agents; Injections, Intraperitoneal; Liver Diseases; Male; Rats; Rats, Wistar; Serum Albumin; Triglycerides | 1997 |
Green tea suppresses D-galactosamine-induced liver injury in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dietary Supplements; Galactosamine; Liver Diseases; Male; Plant Extracts; Rats; Rats, Wistar; Tea | 1998 |
Effect of 4-phenyl-1,3-dithia-2-thioxo-cyclopent-4-ene on liver injury induced by repeated exposure to galactosamine plus carbon tetrachloride in rats.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Galactosamine; Heterocyclic Compounds, 1-Ring; Liver Diseases; Male; Rats; Rats, Wistar; Thioacetamide; Thiones | 1998 |
Endothelin 1 aggravates acute liver injury in perfused livers of rats after treatment with D-galactosamine.
Topics: Acute Disease; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Galactosamine; Hemodynamics; L-Lactate Dehydrogenase; Liver; Liver Circulation; Liver Diseases; Male; Perfusion; Rats; Rats, Sprague-Dawley; Thromboxane A2 | 1998 |
Aggravating action of zymosan on acute liver damage in perfused liver of rats treated with D-galactosamine.
Topics: Acute Disease; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Eicosanoids; Gadolinium; Galactosamine; Hemodynamics; Immunohistochemistry; L-Lactate Dehydrogenase; Liver; Liver Circulation; Liver Diseases; Macrophages; Male; Perfusion; Permeability; Rats; Rats, Sprague-Dawley; Reference Values; Zymosan | 1998 |
Increased serum levels and sinusoidal expression of thrombomodulin in acute liver damage.
Topics: Acute Disease; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Male; Rabbits; Rats; Rats, Sprague-Dawley; Thrombomodulin | 1999 |
Antihepatotoxic activity of Swertia chirata on paracetamol and galactosamine induced hepatotoxicity in rats.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Galactosamine; Liver Diseases; Liver Function Tests; Male; Phytotherapy; Plant Extracts; Rats | 1999 |
Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin.
Topics: Alanine Transaminase; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Creatine Kinase; Female; Flavanones; Flavonoids; Galactosamine; In Situ Nick-End Labeling; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha | 1999 |
Inhibitory effect of tetrahydroswertianolin on tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
Topics: Analysis of Variance; Animals; Apoptosis; Chemical and Drug Induced Liver Injury; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Galactosamine; Glucosides; Iridoid Glucosides; Iridoids; Lipopolysaccharides; Liver Diseases; Male; Mice; Protective Agents; Tumor Necrosis Factor-alpha | 1999 |
Ameliorative effect of an urinary preparation on acetaminophen and D-galactosamine induced hepatotoxicity in rats.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Glutathione; Humans; Lipid Peroxidation; Liver; Liver Diseases; Male; Rats; Rats, Wistar; Urine | 1999 |
Effects of D-galactosamine hydrochloride and partial hepatectomy on spontaneous hepatic injury and hepatocarcinogenesis in Long-Evans Cinnamon rats.
Topics: Aging; Animals; Cell Division; Copper; Female; Fibrosis; Galactosamine; Hepatectomy; Immunohistochemistry; Liver Diseases; Liver Neoplasms; Male; Rats; Rats, Inbred LEC; Stereoisomerism; Survival Rate | 1999 |
Teas and other beverages suppress D-galactosamine-induced liver injury in rats.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Beverages; Blood Glucose; Cacao; Caffeine; Central Nervous System Stimulants; Chemical and Drug Induced Liver Injury; Coffee; Dietary Fiber; Galactosamine; Liver Diseases; Male; Organ Size; Rats; Rats, Wistar; Tea; Weight Gain | 1999 |
Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries.
Topics: Alanine Transaminase; Aniline Hydroxylase; Animals; Antioxidants; Aspartate Aminotransferases; Bepridil; Biphenyl Compounds; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Free Radical Scavengers; Free Radicals; Galactosamine; Ghana; Glutathione Transferase; Lipid Peroxidation; Liver; Liver Diseases; Male; Mice; Microsomes, Liver; Picrates; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances | 1999 |
Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand.
Topics: Animals; Apoptosis; Carrier Proteins; Chemical and Drug Induced Liver Injury; DNA Fragmentation; Fas Ligand Protein; fas Receptor; Female; Galactosamine; Gene Expression; Lipopolysaccharides; Liver; Liver Diseases; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mutation; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; RNA, Messenger; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha | 2000 |
LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor.
Topics: Alanine Transaminase; Animals; Antigens, CD; Apoptosis; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Female; Galactosamine; Lipopolysaccharides; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha | 2000 |
Pathophysiologic importance of E- and L-selectin for neutrophil-induced liver injury during endotoxemia in mice.
Topics: Animals; Antibodies; Chemical and Drug Induced Liver Injury; E-Selectin; Endothelium, Vascular; Endotoxemia; Galactosamine; L-Selectin; Liver; Liver Circulation; Liver Diseases; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Neutrophils | 2000 |
Liver injury suppressing compounds from avocado (Persea americana).
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Persea; Phytotherapy; Rats | 2001 |
1-O-galloyl-6-O-(4-hydroxy-3,5-dimethoxy)benzoyl-beta-D-glucose, a new hepatoprotective constituent from Combretum quadrangulare.
Topics: Animals; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Galactosamine; Glycosides; Hepatocytes; Liver; Liver Diseases; Mice; Molecular Structure; Plant Extracts; Plants, Medicinal; Seeds; Tumor Necrosis Factor-alpha | 2001 |
Effects of bergenin, the major constituent of Mallotus japonicus against D-galactosamine-induced hepatotoxicity in rats.
Topics: Animals; Anti-Ulcer Agents; Benzopyrans; Chemical and Drug Induced Liver Injury; Galactosamine; Glutathione; Lipid Peroxidation; Liver Diseases; Malondialdehyde; Rats; Rats, Sprague-Dawley | 2001 |
Medicinal foodstuffs. XXV. Hepatoprotective principle and structures of ionone glucoside, phenethyl glycoside, and flavonol oligoglycosides from young seedpods of garden peas, Pisum sativum L.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Flavanones; Flavonoids; Galactosamine; Glucosides; Glycosides; Hepatocytes; Injections, Intraperitoneal; Lipopolysaccharides; Liver Diseases; Male; Mice; Pisum sativum; Plant Extracts; Plants, Medicinal; Seeds | 2001 |
[Quantitative assay of metabolic rate of para-aminobenzoic acid combining glycine for the assessment of rabbit liver function].
Topics: 4-Aminobenzoic Acid; Animals; Galactosamine; Glycine; Liver; Liver Diseases; Liver Function Tests; Male; Metabolic Clearance Rate; Models, Animal; Rabbits | 2001 |
Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Galactosamine; Humans; Lipopolysaccharides; Liver; Liver Diseases; Longevity; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Mice, Transgenic; Necrosis; Recombinant Proteins; Species Specificity; Tumor Necrosis Factor-alpha | 2001 |
Protective effect of Linomide on TNF-alpha-induced hepatic injury.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Adhesion; Cell Communication; Chemical and Drug Induced Liver Injury; Endothelium, Vascular; Galactosamine; Hydroxyquinolines; Leukocytes; Liver; Liver Diseases; Male; Microcirculation; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2002 |
Tumor necrosis factor-alpha-null mice are not resistant to cadmium chloride-induced hepatotoxicity.
Topics: Alanine Transaminase; Animals; Apoptosis; Cadmium Chloride; Caspase 3; Caspases; Chemical and Drug Induced Liver Injury; Galactosamine; Histocytochemistry; L-Iditol 2-Dehydrogenase; Lipopolysaccharides; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Tumor Necrosis Factor-alpha | 2002 |
4-Nitrobenzylidene malononitrile reduces apoptosis-mediated liver injury in mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Disease Models, Animal; Enzyme Inhibitors; Female; Galactosamine; Hepatocytes; In Situ Nick-End Labeling; Liver Diseases; Mice; Mice, Inbred BALB C; Transaminases; Tumor Necrosis Factor-alpha; Tyrphostins | 2002 |
Hepatoprotective effect of majonoside R2, the major saponin from Vietnamese ginseng (Panax vietnamensis).
Topics: Animals; Apoptosis; Carbohydrate Sequence; Chemical and Drug Induced Liver Injury; Galactosamine; Ginsenosides; Hepatocytes; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Molecular Structure; Panax; Plant Extracts; Saponins; Tumor Necrosis Factor-alpha; Vietnam | 2002 |
[Clinical and experimental histochemical studies on the activities of liver lysosomal enzymes and gamma-glutamyl transpeptidase (gamma-GTP) (author's transl)].
Topics: Acetylglucosaminidase; Acid Phosphatase; Adenosine Triphosphatases; Alcoholism; Animals; Anticonvulsants; Chemical and Drug Induced Liver Injury; Ethanol; Galactosamine; gamma-Glutamyltransferase; Glucuronidase; Histocytochemistry; Humans; Liver; Liver Diseases; Lysosomes; Male; Phenobarbital; Rats | 1978 |
Dissociation of alpha-macrofetoprotein and alpha-fetoprotein production during experimental injury.
Topics: alpha-Fetoproteins; alpha-Macroglobulins; Animals; Carbon Tetrachloride; Ethionine; Galactosamine; Hepatectomy; Inflammation; Liver; Liver Diseases; Male; Rats | 1979 |
Studies of liver phosphorylase in hepatic injuries. I. Alteration in enzyme activity.
Topics: Animals; Carbon Tetrachloride Poisoning; Galactosamine; Hepatectomy; Humans; Liver; Liver Diseases; Male; Phosphorylases; Rats | 1978 |
An animal model of fulminant hepatic failure in the rat.
Topics: Amino Acids; Animals; Brain; Brain Chemistry; Brain Edema; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Liver; Liver Diseases; Male; Rats | 1979 |
Galactosamine-induced sensitization to the lethal effects of endotoxin.
Topics: Animals; Chemical and Drug Induced Liver Injury; Drug Synergism; Endotoxins; Female; Galactosamine; L-Iditol 2-Dehydrogenase; Lipid A; Lipopolysaccharides; Liver Diseases; Male; Mice; Rabbits; Rats; Salmonella; Time Factors; Uridine | 1979 |
Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Liver; Liver Diseases; Liver Transplantation; Male; Rats | 1979 |
Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.
Topics: Animals; Artificial Organs; Aspartate Aminotransferases; Bilirubin; Charcoal; Chemical and Drug Induced Liver Injury; Cross Circulation; Galactosamine; Hemoperfusion; Liver; Liver Diseases; Male; Necrosis; Prothrombin Time; Rats | 1979 |
Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
Topics: Albumins; Animals; Artificial Organs; Charcoal; Collodion; Disease Models, Animal; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Humans; Liver; Liver Diseases; Rats | 1977 |
Lipoprotein and lecithin: cholesterol acyltransferase changes in galactosamine-induced rat liver injury.
Topics: Acyltransferases; Animals; Apoproteins; Chemical and Drug Induced Liver Injury; Cholesterol Esters; Disease Models, Animal; Female; Galactosamine; Lecithin Cholesterol Acyltransferase Deficiency; Lipid Metabolism, Inborn Errors; Lipoproteins; Liver Diseases; Phosphatidylcholine-Sterol O-Acyltransferase; Rats | 1975 |
[Diaminooxidase (histaminase) in liver diseases and experimental liver lesions].
Topics: Amine Oxidase (Copper-Containing); Animals; Chemical and Drug Induced Liver Injury; Female; Galactosamine; Guinea Pigs; Liver Diseases | 1976 |
Protective effect of ammonium ions and L-norvaline on galactosamine induced liver injury.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Female; Galactosamine; Glutamate Dehydrogenase; Liver; Liver Diseases; Ornithine Carbamoyltransferase; Quaternary Ammonium Compounds; Rats; Uracil Nucleotides | 1977 |
[(Blood coagulation disturbances of rats after acute liver damage produced by D-galactosamin-HCl) (author's transl)].
Topics: Animals; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Fibrinolysis; Galactosamine; Hematocrit; Hemostasis; Liver Diseases; Platelet Aggregation; Rats | 1977 |
Phospholipids in endoplasmic reticulum - their relationship to drug metabolism in experimental liver disease.
Topics: 1-Naphthylisothiocyanate; Animals; Cholestasis; Choline Deficiency; Endoplasmic Reticulum; Galactosamine; Hepatitis; Liver Diseases; Phospholipids; Rats | 1977 |
Early, reversible plasma membrane injury in galactosamine-induced liver cell death.
Topics: Animals; Calcium; Cell Membrane; Cell Survival; Chemical and Drug Induced Liver Injury; Circular Dichroism; Copper; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Female; Galactosamine; Liver; Liver Diseases; Molecular Conformation; Nucleotidases; Protein Biosynthesis; Rats; RNA; Time Factors; Uridine | 1975 |
[Proceedings: Inhibition of D-galactosamine-induced damage to liver cells through D-fructose administration].
Topics: Animals; Fructose; Galactosamine; Liver; Liver Diseases; Necrosis; Rats | 1975 |
Modification of the hepatotoxicity of D-galactosamine in the rat by cycloheximide.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cycloheximide; Galactosamine; Liver; Liver Diseases; Necrosis; Protein Biosynthesis; Rats; Triglycerides | 1976 |
Ongoing hepatocellular regeneration and resiliency toward galactosamine hepatotoxicity.
Topics: Aging; Alanine Transaminase; Animals; Aspartate Aminotransferases; Autoradiography; Chemical and Drug Induced Liver Injury; DNA; Female; Galactosamine; Liver; Liver Diseases; Liver Glycogen; Liver Regeneration; Male; Necrosis; Pregnancy; Rats; Rats, Sprague-Dawley; Time Factors; Uracil Nucleotides | 1992 |
Arachidonate metabolism in D-galactosamine or carbon tetrachloride-induced acute and chronic liver injuries in rats.
Topics: Acute Disease; Animals; Arachidonic Acids; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chronic Disease; Eicosanoids; Galactosamine; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipopolysaccharides; Liver; Liver Cirrhosis, Experimental; Liver Diseases; Male; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar | 1992 |
Protective effect of zinc on liver injury induced by D-galactosamine in rats.
Topics: Animals; Brain; Cell Separation; Chemical and Drug Induced Liver Injury; Galactosamine; Injections, Intraperitoneal; Liver; Liver Diseases; Liver Function Tests; Male; Rats; Rats, Wistar; Zinc | 1992 |
Hepatic D-galactosamine toxicity studied with localized in vivo 31P magnetic resonance spectroscopy in intact rats.
Topics: Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Galactosamine; Liver Diseases; Magnetic Resonance Spectroscopy; Phosphocreatine; Phosphoric Diester Hydrolases; Phosphoric Monoester Hydrolases; Phosphorus; Rats; Rats, Inbred Strains | 1991 |
Pharmacokinetics, neuromuscular effects, and biodisposition of 3-desacetylvecuronium (Org 7268) in cats.
Topics: Animals; Cats; Chemical and Drug Induced Liver Injury; Female; Galactosamine; Kidney Diseases; Liver Diseases; Male; Neuromuscular Blocking Agents; Tissue Distribution; Vecuronium Bromide | 1991 |
Effects of intraperitoneal transplantation of microcarrier-attached hepatocytes on D-galactosamine-induced acute liver failure in rats.
Topics: Acute Disease; Albumins; Animals; Bile Acids and Salts; Cells, Cultured; Chemical and Drug Induced Liver Injury; Dextrans; Galactosamine; Liver; Liver Diseases; Liver Transplantation; Male; Microspheres; Peritoneal Cavity; Prealbumin; Rats | 1990 |
Targeted protection of hepatocytes from galactosamine toxicity in vivo.
Topics: alpha-Fetoproteins; Animals; Asialoglycoprotein Receptor; Asialoglycoproteins; Behavior, Animal; Chemical and Drug Induced Liver Injury; Female; Fetuins; Galactosamine; Injections, Intravenous; Iodine Radioisotopes; Liver; Liver Diseases; Polylysine; Rats; Rats, Inbred Strains; Receptors, Immunologic; Uridine Monophosphate | 1990 |
Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine.
Topics: alpha-Fetoproteins; Animals; Bile Ducts; Binding Sites; Biomarkers; Cell Division; Chemical and Drug Induced Liver Injury; Galactosamine; Immunohistochemistry; Lectins; Liver; Liver Diseases; Male; Nucleic Acid Hybridization; Peanut Agglutinin; Phenotype; Rats; Rats, Inbred F344; Rats, Inbred Strains; Reference Values | 1991 |
The acute-phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor-alpha.
Topics: Absorption; Acute-Phase Reaction; Animals; Drug Synergism; Endotoxins; Escherichia coli; Galactosamine; Liver Diseases; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha; Turpentine | 1992 |
Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model.
Topics: Animals; Cell-Free System; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; DNA; Galactosamine; Growth Inhibitors; Interleukin-6; Leukemia Inhibitory Factor; Liver; Liver Diseases; Liver Regeneration; Lymphokines; Male; Rats; Rats, Inbred Strains; Survival Rate; Thymidine | 1991 |
Physicochemical characteristics of hepatic stimulatory factor prepared from cell free supernatant of hepatocyte cultures.
Topics: Acrylic Resins; Autoradiography; Calibration; Cell-Free System; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chromatography, Gel; Disease Models, Animal; DNA; Galactosamine; Growth Inhibitors; Hot Temperature; Interleukin-6; Leukemia Inhibitory Factor; Liver; Liver Diseases; Liver Regeneration; Lymphokines; Molecular Weight; Proteins; Survival Rate; Thymidine; Trypsin | 1991 |
Influence of liver damage on antipyrine metabolite formation in rats.
Topics: 1-Naphthylisothiocyanate; Animals; Antipyrine; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Male; Rats; Rats, Inbred Strains | 1991 |
The protective effects of (4R)-hexahydro-7,7-dimethyl-6-oxo-1,2,5-dithiazocine-4-carboxylic acid (SA3443), a novel cyclic disulfide, on chemically-induced acute liver injury.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Azocines; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disulfides; Ethionine; Galactosamine; Lipid Peroxides; Liver Diseases; Male; Rats; Rats, Inbred Strains; Triglycerides | 1991 |
Plasma gamma-aminobutyric acid in experimental fulminant hepatic failure of rats and its diagnostic value in hepatic encephalopathy.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Liver Diseases; Male; Rats; Rats, Inbred Strains | 1990 |
A new perchloric acid treatment of human plasma for detection of endotoxin by an endotoxin-specific chromogenic test.
Topics: Animals; Bacterial Infections; Chromogenic Compounds; Colorimetry; Endotoxins; Fever; Galactosamine; Humans; Limulus Test; Lipopolysaccharides; Liver Diseases; Mice; Perchlorates; Rabbits | 1990 |
Human hepatic regenerative stimulator substance: partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells.
Topics: Animals; Cell Division; Chemical and Drug Induced Liver Injury; Female; Fetus; Galactosamine; Growth Substances; Hepatectomy; Humans; Liver; Liver Diseases; Liver Regeneration; Male; Mice; Mice, Inbred Strains; Necrosis; Rats; Rats, Inbred Strains | 1990 |
The effect of liver dysfunction on colchicine pharmacokinetics in the rat.
Topics: 1-Naphthylisothiocyanate; Animals; Cholestasis; Cimetidine; Colchicine; Cytochrome P-450 Enzyme Inhibitors; Galactosamine; Liver Diseases; Rats; Rats, Inbred Strains | 1990 |
[31P nuclear magnetic resonance study of intrahepatic energy metabolism in acute liver failure].
Topics: Acute Disease; Animals; Chemical and Drug Induced Liver Injury; Energy Metabolism; Galactosamine; Hydrogen-Ion Concentration; Liver; Liver Diseases; Magnetic Resonance Spectroscopy; Male; Phosphorus; Rats; Rats, Inbred Strains | 1990 |
Effects of putrescine on D-galactosamine-induced acute liver failure in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Liver Regeneration; Male; Polyamines; Putrescine; Rats; Rats, Inbred Strains; Survival Analysis; Thymidine | 1990 |
[Use of hepatocytes cultured in microcarriers for correction of acute hepatic insufficiency].
Topics: Acute Disease; Albumins; Animals; Bilirubin; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Culture Media; Galactosamine; Liver; Liver Diseases; Male; Microscopy, Electron, Scanning; Polystyrenes; Rats; Rats, Inbred Strains; Time Factors | 1990 |
[Hepatocyte transplantation - development of a clinical model].
Topics: Animals; Cell Separation; Cell Survival; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Histocytochemistry; Injections; Injections, Intraperitoneal; Liver; Liver Diseases; Liver Transplantation; Rats; Rats, Inbred Strains; Spleen; Swine; Transplantation | 1987 |
Tryptophan metabolism in D-galactosamine-induced liver injury.
Topics: Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Galactosamine; Hydroxyindoleacetic Acid; Indoleacetic Acids; Liver; Liver Diseases; Rats; Rats, Inbred Strains; Serotonin; Tryptamines; Tryptophan | 1988 |
MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
Topics: Animals; Chemical and Drug Induced Liver Injury; Contrast Media; Edetic Acid; Ethanol; Galactosamine; Liver; Liver Diseases; Magnetic Resonance Imaging; Manganese; Pyridoxal Phosphate; Rabbits; Time Factors | 1989 |
[Protective effects of DBcAMP on acute liver failure induced by D-galactosamine in rats].
Topics: Acute Disease; Adenosine Triphosphate; Animals; Blood Glucose; Bucladesine; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Circulation; Liver Diseases; Liver Function Tests; Male; Necrosis; Rats; Rats, Inbred Strains | 1989 |
Production of leukotriene B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxin.
Topics: Acute Disease; Animals; Chemical and Drug Induced Liver Injury; Endotoxins; Galactosamine; Leukotriene B4; Lipopolysaccharides; Liver; Liver Diseases; Male; Rats; Salmonella enteritidis | 1989 |
[The effect of pollen on the changes in the liver of laboratory rats evoked by ethionine, carbon tetrachloride, allyl alcohol and galactosamine].
Topics: 1-Propanol; Animals; Carbon Tetrachloride; Ethionine; Galactosamine; Liver; Liver Diseases; Male; Plant Extracts; Pollen; Propanols; Rats; Rats, Inbred Strains; Secale | 1989 |
Fetal liver allo- and xenotransplantation in acute and chronic hepatic failure.
Topics: Acute Disease; Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chronic Disease; Fetus; Freezing; Galactosamine; Liver; Liver Diseases; Liver Transplantation; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous; Transplantation, Homologous | 1989 |
Decrease in the number of receptors for epidermal growth factor in the liver of D-galactosamine-intoxicated rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Epidermal Growth Factor; ErbB Receptors; Galactosamine; Indicator Dilution Techniques; Liver; Liver Diseases; Male; Rats; Rats, Inbred Strains | 1989 |
Effect of hepatic failure toxins on regenerative enzymes in the liver after injury with galactosamine in the rat.
Topics: Acetaminophen; Ammonium Chloride; Animals; Caprylates; Chemical and Drug Induced Liver Injury; Disulfides; Galactosamine; Hepatic Encephalopathy; Liver Diseases; Liver Regeneration; Male; Ornithine Decarboxylase Inhibitors; Rats; Rats, Inbred Strains; Thymidine Kinase; Time Factors | 1989 |
[Role of singlet oxygen in pathogenesis of liver injury in rats treated with D-galactosamine].
Topics: Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Lipid Peroxidation; Liver; Liver Diseases; Luminescent Measurements; Male; Necrosis; Oxygen; Rats; Rats, Inbred Strains; Singlet Oxygen; Vitamin E | 1989 |
[Studies on the effect of liver cytosol on experimental acute hepatic failure in the rat].
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytosol; Dogs; Fetus; Galactosamine; Humans; Liver; Liver Diseases; Liver Regeneration; Male; Rats; Rats, Inbred Strains | 1989 |
Changes in endogenous prostaglandin levels during D-galactosamine-induced liver injury.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Galactosamine; Indomethacin; Liver Diseases; Male; Necrosis; Prostaglandins; Rats; Rats, Inbred Strains | 1989 |
Influence of somatostatin on galactosamine-induced liver injury.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Male; Octreotide; Rats; Somatostatin | 1986 |
[Pharmacological studies on schizandra fruits. III. Effects of wuweizisu C, a lignan component of schizandra fruits, on experimental liver injuries in rats].
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cyclooctanes; Ethionine; Fatty Liver; Galactosamine; Hepatitis; Lignans; Liver Diseases; Male; Plant Extracts; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Inbred Strains | 1985 |
Biochemical effects of acute stress on energy metabolism in liver damaged rats.
Topics: Acetyl Coenzyme A; Animals; Chemical and Drug Induced Liver Injury; Cyclic AMP; Cyclic GMP; Energy Metabolism; Galactosamine; Ketone Bodies; Lactates; Lactic Acid; Liver Diseases; Male; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains; Stress, Physiological | 1987 |
Renin-angiotensin system, blood pressure homeostasis and renal function in galactosamine-induced fulminant hepatic failure in the guinea pig.
Topics: Angiotensinogen; Animals; Blood Pressure; Chemical and Drug Induced Liver Injury; Galactosamine; Guinea Pigs; Homeostasis; Kidney; Liver Diseases; Male; Renin; Renin-Angiotensin System | 1988 |
Hepatoprotective activity of kutkin--the iridoid glycoside mixture of Picrorhiza kurrooa.
Topics: Animals; Cinnamates; Female; Galactosamine; Glycosides; Hydroxybenzoates; Liver Diseases; Malaria; Male; Muridae; Plasmodium berghei; Rats; Rats, Inbred Strains; Vanillic Acid | 1988 |
Microencapsulated hepatocytes for bioartificial liver support.
Topics: Albumins; Animals; Artificial Organs; Cell Survival; Chemical and Drug Induced Liver Injury; Drug Compounding; Electrophoresis, Polyacrylamide Gel; Galactosamine; Liver; Liver Diseases; Liver Transplantation; Male; Rats; Rats, Inbred Strains | 1988 |
Dynamic relationship between urea and glutamine synthesis in the mechanism of ammonia detoxication: a tracer study using 15NH4Cl in fulminant hepatic failure rats.
Topics: Ammonia; Ammonium Chloride; Animals; Blood Urea Nitrogen; Chemical and Drug Induced Liver Injury; Galactosamine; Glutamine; Liver Diseases; Male; Nitrogen Isotopes; Rats; Rats, Inbred Strains; Urea | 1988 |
[Evaluation of serum cathepsin B-like activity in liver diseases].
Topics: Animals; Carbon Tetrachloride; Cathepsin B; Chemical and Drug Induced Liver Injury; Galactosamine; Humans; Liver Diseases; Male; Rats; Rats, Inbred Strains | 1988 |
Reversal of liver failure in rats by ultraviolet-irradiated hepatocyte transplantation.
Topics: Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Liver Regeneration; Liver Transplantation; Rats; Rats, Inbred WF; Transplantation, Heterotopic; Transplantation, Homologous | 1987 |
Partial purification and characterization of hepatocyte proliferation stimulatory factor from liver of rats treated with D-galactosamine.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chemical Precipitation; Chromatography; Dialysis; DNA; Epidermal Growth Factor; Galactosamine; Growth Substances; Hot Temperature; Hydrogen-Ion Concentration; Insulin; Liver; Liver Diseases; Male; Rats; Rats, Inbred Strains; Trypsin | 1988 |
Contribution of hepatic reticuloendothelial system to glomerular IgA deposition in rat liver injury.
Topics: Alanine Transaminase; Animals; Carbon; Chemical and Drug Induced Liver Injury; Chemical Fractionation; Dimethylnitrosamine; Galactosamine; Immunoglobulin A; Kidney Glomerulus; Liver; Liver Diseases; Male; Molecular Weight; Mononuclear Phagocyte System; Rats; Rats, Inbred Strains | 1988 |
[Effect of putrescine on experimental acute hepatic injury in rats].
Topics: Animals; Chemical and Drug Induced Liver Injury; Female; Galactosamine; Liver; Liver Diseases; Putrescine; Rats; Rats, Inbred Strains | 1988 |
Protective effect of malotilate against galactosamine intoxication in the rat.
Topics: Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Liver Function Tests; Male; Malonates; Rats; Rats, Inbred Strains | 1987 |
Transplantation of cryopreserved hepatocytes or liver cytosol injection in the treatment of acute liver failure in rats.
Topics: Acute Disease; Animals; Aspartate Aminotransferases; Bilirubin; Cell Separation; Cell Survival; Cytosol; Fibrinogen; Freezing; Galactosamine; Injections, Intraperitoneal; Liver Diseases; Liver Transplantation; Male; Partial Thromboplastin Time; Rats; Rats, Inbred Lew; Tissue Preservation | 1986 |
[Prostacyclin and other drugs protective against experimental liver damage in rats].
Topics: Acute Disease; Animals; Chemical and Drug Induced Liver Injury; Drug Synergism; Epoprostenol; Female; Galactosamine; Liver Diseases; Male; Neostigmine; Prostaglandins F; Rats; Rats, Inbred Strains; Solanaceous Alkaloids | 1986 |
[Effects of gomisin A, a lignan component of Schizandra fruits, on experimental liver injuries and liver microsomal drug-metabolizing enzymes].
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cyclooctanes; Dioxoles; Ethionine; Galactosamine; Lignans; Liver Diseases; Male; Microsomes, Liver; Mixed Function Oxygenases; Protein Biosynthesis; Rats; Rats, Inbred Strains; Sleep | 1986 |
Membrane lipid changes in erythrocytes, liver and kidney in acute and chronic experimental liver disease in rats.
Topics: Acute Disease; Animals; Bile Ducts; Cell Membrane; Chemical and Drug Induced Liver Injury; Cholesterol; Chronic Disease; Erythrocyte Membrane; Galactosamine; Hepatitis; Kidney Cortex; Liver; Liver Diseases; Male; Membrane Lipids; Microsomes; Microsomes, Liver; Microvilli; Phospholipids; Rats; Rats, Inbred Strains; Triglycerides | 1987 |
[Experimental study on the role of endotoxin in the mechanism of galactosamine-induced liver injury].
Topics: Animals; Chemical and Drug Induced Liver Injury; Endotoxins; Galactosamine; Liver; Liver Diseases; Male; Mitochondria, Liver; Necrosis; Oxygen Consumption; Rats; Rats, Inbred Strains | 1986 |
Chronic liver disease animal model for evaluation of artificial liver support systems.
Topics: Animals; Body Weight; Chronic Disease; Disease Models, Animal; Dogs; Fibrinogen; Galactosamine; Hepatitis, Chronic; Liver Diseases; Male; Necrosis; Partial Thromboplastin Time; Prothrombin Time | 1985 |
Effect of viable isolated hepatocytes or hepatocyte fractions on survival rate following galactosamine-induced acute liver failure.
Topics: Acute Disease; Animals; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Liver Transplantation; Male; Rats; Rats, Inbred BN; Rats, Inbred Strains | 1985 |
Metabolism of branched-chain amino acids in rats with acute hepatic failure: a tracer study using 15N-leucine.
Topics: Alanine; Amino Acids, Branched-Chain; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Glucagon; Glutamine; Insulin; Isoleucine; Leucine; Liver Diseases; Male; Rats; Rats, Inbred Strains; Valine | 1985 |
Assay procedures for cathepsin B, H and L activities in rat tissue homogenates.
Topics: Animals; Cathepsin B; Cathepsin H; Cathepsin L; Cathepsins; Clinical Enzyme Tests; Cysteine Endopeptidases; Endopeptidases; Galactosamine; Liver; Liver Diseases; Liver Extracts; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1986 |
[Substance-induced liver injury as a model for evaluating hepatoprotective drugs].
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug Evaluation, Preclinical; Galactosamine; Liver Diseases; Rabbits; Rats; Rats, Inbred Strains; Thioacetamide | 1985 |
Effects of regenerating liver cytosol on drug-induced hepatic failure.
Topics: Animals; Bilirubin; Blood Glucose; Chemical and Drug Induced Liver Injury; Cytosol; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Fat Emulsions, Intravenous; Galactosamine; Hepatectomy; Liver Diseases; Liver Regeneration; Male; Mononuclear Phagocyte System; Rats; Rats, Inbred Strains | 1985 |
The effect of acute liver damage on circulating ferritin levels in vivo and in the isolated perfused rat liver.
Topics: Animals; Chemical and Drug Induced Liver Injury; Ferritins; Galactosamine; In Vitro Techniques; Leucine; Liver; Liver Diseases; Male; Phagocytosis; Protein Biosynthesis; Rats; Rats, Inbred Strains | 1985 |
Antinecrotic effect of 3-palmitoyl-(+)-catechin against liver damage induced by galactosamine or ethanol in the rat.
Topics: Animals; Benzopyrans; Catechin; Chemical and Drug Induced Liver Injury; Ethanol; Galactosamine; Hypoxia; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains | 1985 |
Alternations of liver pathophysiology in experimental hepatic failure treated by two forms of plasma purification procedure.
Topics: Adenine Nucleotides; Animals; Chemical and Drug Induced Liver Injury; Cross Circulation; Galactosamine; Hemoperfusion; Liver Diseases; Liver Function Tests; Male; Mitochondria, Liver; Parabiosis; Rats | 1985 |
Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis.
Topics: Animals; Calcium; Chelating Agents; Chemical and Drug Induced Liver Injury; Cystamine; Cysteamine; Galactosamine; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1985 |
Ultrastructural study of liver cell injury due to UTP deficiency.
Topics: Animals; Azauridine; Cell Nucleolus; Chemical and Drug Induced Liver Injury; Cytoplasm; Endoplasmic Reticulum; Female; Galactosamine; Galactose; Golgi Apparatus; Injections, Intraperitoneal; Liver; Liver Diseases; Microscopy, Electron; Mitochondria; Rats; Ribosomes; Time Factors; Uracil Nucleotides; Uridine | 1974 |
[Enzyme histochemical findings in the rat liver following galactosamine lesions and cholinorotate].
Topics: Acid Phosphatase; Adenosine Triphosphatases; Alkaline Phosphatase; Animals; Chemical and Drug Induced Liver Injury; Choline; Galactosamine; Hepatitis A; Histocytochemistry; Humans; Liver Diseases; Orotic Acid; Rats; Succinate Dehydrogenase | 1972 |
[Relationship between lecithin-lysolecithin and cholesterol-cholesterol esters in the serum of the rat with galactosamine-induced hepatosis].
Topics: Acute Disease; Acyltransferases; Animals; Chemical and Drug Induced Liver Injury; Cholesterol; Esters; Galactosamine; Injections, Intraperitoneal; Liver; Liver Diseases; Lysophosphatidylcholines; Male; Phosphatidylcholines; Rats; Time Factors | 1972 |
Glycosyltransferases in human blood. II. Study of serum galactosyltransferase and N-acetylgalactosaminyltransferase in patients with liver diseases.
Topics: Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Cystic Fibrosis; Galactosamine; Galactose; Hepatitis A; Hexosyltransferases; Humans; Liver; Liver Cirrhosis; Liver Diseases; Methods; Oligosaccharides; Transferases | 1972 |
[Acute hepatic disorders].
Topics: Acute Disease; Alcoholism; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Dogs; Galactosamine; Guinea Pigs; Humans; Liver Diseases; Mice; Orotic Acid; Rabbits; Rats | 1972 |
[Cholinesterase activity in rabbit plasma after severe hepatic damage caused by D-galactosamine-HCl].
Topics: Acetylcholine; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cholinesterases; Galactosamine; Hexosamines; Liver Diseases; Poisoning; Rabbits; Serum Albumin | 1971 |
[Electron optic studies on galactosamine-induced lesions in the rat liver].
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytoplasm; Disease Models, Animal; Female; Galactosamine; Hexosamines; Liver Diseases; Microscopy, Electron; Mitochondria, Liver; Rats | 1971 |